MA54133B1 - Composés d'aminopyrazine diol utilisés comme inhibiteurs de pi3k-y - Google Patents

Composés d'aminopyrazine diol utilisés comme inhibiteurs de pi3k-y

Info

Publication number
MA54133B1
MA54133B1 MA54133A MA54133A MA54133B1 MA 54133 B1 MA54133 B1 MA 54133B1 MA 54133 A MA54133 A MA 54133A MA 54133 A MA54133 A MA 54133A MA 54133 B1 MA54133 B1 MA 54133B1
Authority
MA
Morocco
Prior art keywords
pi3k
inhibitors
aminopyrazine
compounds used
diol compounds
Prior art date
Application number
MA54133A
Other languages
English (en)
Other versions
MA54133A (fr
Inventor
Nikoo Falahatpisheh
Andrew P Combs
Stacey Shepard
Lixin Shao
Original Assignee
Incyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp filed Critical Incyte Corp
Publication of MA54133A publication Critical patent/MA54133A/fr
Publication of MA54133B1 publication Critical patent/MA54133B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • C07D241/28—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms in which said hetero-bound carbon atoms have double bonds to oxygen, sulfur or nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Cette invention concerne des composés de formule (i) : (i) ou des sels pharmaceutiquement acceptables de ceux-ci, qui sont des inhibiteurs de pi3k-y qui sont utiles pour le traitement de troubles tels que les maladies auto-immunes, le cancer, les maladies cardiovasculaires et les maladies neurodégénératives.
MA54133A 2018-03-08 2019-03-07 Composés d'aminopyrazine diol utilisés comme inhibiteurs de pi3k-y MA54133B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862640276P 2018-03-08 2018-03-08
US201862702230P 2018-07-23 2018-07-23
US201862745873P 2018-10-15 2018-10-15

Publications (2)

Publication Number Publication Date
MA54133A MA54133A (fr) 2021-01-13
MA54133B1 true MA54133B1 (fr) 2022-01-31

Family

ID=67844335

Family Applications (1)

Application Number Title Priority Date Filing Date
MA54133A MA54133B1 (fr) 2018-03-08 2019-03-07 Composés d'aminopyrazine diol utilisés comme inhibiteurs de pi3k-y

Country Status (32)

Country Link
US (5) US10669262B2 (fr)
EP (2) EP3762368B1 (fr)
JP (2) JP7268049B2 (fr)
KR (2) KR102828717B1 (fr)
CN (2) CN118290402A (fr)
AU (2) AU2019272342B2 (fr)
CA (1) CA3093445A1 (fr)
CL (1) CL2020002275A1 (fr)
CO (1) CO2020012169A2 (fr)
CR (2) CR20200464A (fr)
CY (1) CY1125169T1 (fr)
DK (1) DK3762368T3 (fr)
EC (1) ECSP20061378A (fr)
ES (1) ES2910071T3 (fr)
HR (1) HRP20220331T1 (fr)
HU (1) HUE057970T2 (fr)
IL (2) IL302529B2 (fr)
LT (1) LT3762368T (fr)
MA (1) MA54133B1 (fr)
MD (1) MD3762368T2 (fr)
MX (2) MX2020009228A (fr)
PE (2) PE20251292A1 (fr)
PH (1) PH12020551390A1 (fr)
PL (1) PL3762368T3 (fr)
PT (1) PT3762368T (fr)
RS (1) RS63124B1 (fr)
SG (1) SG11202008560VA (fr)
SI (1) SI3762368T1 (fr)
SM (1) SMT202200134T1 (fr)
TW (2) TWI827583B (fr)
UA (1) UA128288C2 (fr)
WO (1) WO2019226213A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR102018007822A2 (pt) 2017-04-20 2018-11-06 Gilead Sciences, Inc. composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição
SG11202006296YA (en) 2018-01-19 2020-08-28 Cytokinetics Inc Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors
WO2019160882A1 (fr) 2018-02-13 2019-08-22 Gilead Sciences, Inc. Inhibiteurs pd -1/pd-l1
CR20200464A (es) 2018-03-08 2021-04-14 Incyte Corp Compuestos diólicos de aminopirazina como inhibidores de pi3k-y
JP7438148B2 (ja) 2018-06-26 2024-02-26 サイトキネティックス， インコーポレイテッド 心臓サルコメア阻害剤
EP3814343B1 (fr) 2018-06-26 2023-01-11 Cytokinetics, Inc. Inhibiteurs de sarcomères cardiaques
WO2020010003A1 (fr) 2018-07-02 2020-01-09 Incyte Corporation DÉRIVÉS D'AMINOPYRAZINE UTILISÉS EN TANT QU'INHIBITEURS DE PI3K-γ
PE20210642A1 (es) 2018-07-13 2021-03-23 Gilead Sciences Inc Inhibidores de pd-1/pd-l1
WO2021219418A1 (fr) * 2020-04-29 2021-11-04 Basf Se Préparation de carboxyamides aromatiques par réaction de carbonylation catalysée au palladium
CN112341437A (zh) * 2020-12-21 2021-02-09 李寒 一种取代的吡嗪衍生物及其应用
KR20240015622A (ko) 2021-03-04 2024-02-05 싸이토키네틱스, 인코포레이티드 심장 근절 억제제

Family Cites Families (818)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2190837B1 (fr) 1972-06-29 1974-12-27 Rhone Progil
US4705853A (en) 1982-09-30 1987-11-10 A. H. Robins Company, Inc. Fused aromatic oxazepinones, thiazepinones, diazepinones and sulfur analogs thereof
US5025096A (en) 1985-08-22 1991-06-18 Mine Safety Appliances Company Preparation of indole and indole derivatives
US4861884A (en) 1985-10-15 1989-08-29 The Dow Chemical Company Compositions prepared from amino substituted pyrazines and carboxylic acids, carboxylic acid anhydrides, carboxylic acid esters or carboxylic acid halides
US4735321A (en) 1986-05-02 1988-04-05 The Coca-Cola Company Mobile extra display module
GB8718445D0 (en) 1987-08-04 1987-09-09 Wyeth John & Brother Ltd Pyridyl-ethers
JP2691986B2 (ja) 1987-08-28 1997-12-17 チッソ株式会社 ピリジン骨格を有する光学活性化合物の製造法
JPH0782249B2 (ja) 1989-11-09 1995-09-06 キヤノン株式会社 トナー
JPH061776Y2 (ja) 1990-02-14 1994-01-19 関東自動車工業株式会社 樹脂成形用型締装置の上型回転装置
NL9001162A (nl) 1990-05-18 1991-12-16 Stamicarbon Werkwijze ter bereiding van 2-n-acylaminopyridines en 2-aminopyridines uit 5-oxoalkaannitriloximmen alsmede deze 5-oxoalkaannitriloximmen, 2-n-acylaminopyridines en 2-aminopyridines.
US5155117A (en) 1991-04-12 1992-10-13 G. D. Searle & Co. 1-arylheteroarylalkyl substituted-1h-1,2,4-triazole compounds for treatment of circulatory disorders
JPH0558997A (ja) 1991-09-04 1993-03-09 Mitsubishi Kasei Corp チオカルバモイルアセトニトリル誘導体
EP0553009B1 (fr) 1992-01-23 1997-06-04 Institut Francais Du Petrole Catalyseur d'alkylation de paraffines
US5315043A (en) 1992-02-05 1994-05-24 E. I. Du Pont De Nemours And Company Aromatic nucleophilic fluorination
US5521184A (en) 1992-04-03 1996-05-28 Ciba-Geigy Corporation Pyrimidine derivatives and processes for the preparation thereof
US5252737A (en) 1992-05-22 1993-10-12 Monsanto Company Process for preparing N-aliphatic substituted p-phenylenediamines
JPH061776A (ja) 1992-06-18 1994-01-11 Nippon Soda Co Ltd 置換ピラジンカルボニトリルの製造方法
US5232945A (en) 1992-07-20 1993-08-03 Pfizer Inc. 3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives
JPH06256327A (ja) 1993-03-03 1994-09-13 Nippon Soda Co Ltd ４−置換アゼチジノン誘導体の製造方法
JP4327911B2 (ja) 1993-03-03 2009-09-09 日本曹達株式会社 イミド化合物の製造方法
WO1994022853A1 (fr) 1993-03-26 1994-10-13 Shell Internationale Research Maatschappij B.V. 1-heteroaryl-pyrazolidin-3,5-diones herbicides
US5545535A (en) 1993-04-13 1996-08-13 Molecular Probes, Inc. Fluorescent assay for bacterial gram reaction
US5534416A (en) 1993-04-13 1996-07-09 Molecular Probes, Inc. Fluorescent viability assay using cyclic-substituted unsymmetrical cyanine dyes
US5436134A (en) 1993-04-13 1995-07-25 Molecular Probes, Inc. Cyclic-substituted unsymmetrical cyanine dyes
US5451702A (en) 1993-04-26 1995-09-19 Monsanto Company Process for preparing substituted aromatic amines
TW266206B (fr) 1993-04-28 1995-12-21 Takeda Pharm Industry Co Ltd
JPH0782249A (ja) 1993-06-30 1995-03-28 Nippon Soda Co Ltd ４−置換アゼチジノン誘導体の製造法
US5744492A (en) 1993-09-17 1998-04-28 United States Of America Method for inhibiting angiogenesis
US5602156A (en) 1993-09-17 1997-02-11 The United States Of America As Represented By The Department Of Health And Human Services Method for inhibiting metalloproteinase expression
US5430123A (en) 1994-02-04 1995-07-04 Hoechst Celanese Corporation Polymer compositions containing substituted pyrazines
US5459266A (en) 1994-02-04 1995-10-17 Hoechst Celanese Corporation Substituted pyrazines
US5393860A (en) 1994-02-04 1995-02-28 Hoechst Celanese Corporation Polymer compositions containing substituted pyrazines
US5863903A (en) 1994-03-09 1999-01-26 Novo Nordisk A/S Use of hydroxy alkyl piperidine and pyrrolidine compounds to treat diabetes
AU1890295A (en) 1994-03-09 1995-09-25 Novo Nordisk A/S Piperidines and pyrrolidines
DE19509353A1 (de) 1994-03-31 1995-10-05 Basf Ag 4-Aminopiperidine
SE9401353D0 (sv) 1994-04-21 1994-04-21 Pharmacia Ab Novel antitumour compounds with antimitotic activity
DE4417746A1 (de) 1994-05-20 1995-11-23 Bayer Ag Neue Farbstoffe zum Massefärben von Kunststoffen
KR0151819B1 (ko) 1994-06-11 1998-10-15 강박광 신규의 피리딜 n-옥사이드로 치환된 피디딜이미다졸 유도체 및 그의 제조방법
GB9412522D0 (en) 1994-06-22 1994-08-10 Ici Plc Optical recording media
DE4427529A1 (de) 1994-08-04 1996-02-08 Bayer Ag Verfahren zur Herstellung von 1,2,4-Triazin-3,5-dionen
FR2725718B1 (fr) 1994-10-14 1997-01-24 Virbac Lab Bis-2-aminopyridines, leur procede de preparation et leurs applications
US5883106A (en) 1994-10-18 1999-03-16 Pfizer Inc. 5-lipoxygenase inhibitors
SK281577B6 (sk) 1994-10-18 2001-05-10 Pfizer Inc. Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze
JPH08175994A (ja) 1994-10-27 1996-07-09 Takeda Chem Ind Ltd 脂質代謝改善剤
AU697744C (en) 1994-10-27 2002-08-22 Elanco Animal Health Ireland Limited Apolipoprotein-B synthesis inhibitors
US5677459A (en) 1994-11-10 1997-10-14 Sibia Neurosciences, Inc. Methods for the preparation of modulators of acetylcholine receptors
US5703100A (en) 1994-11-10 1997-12-30 Sibia Neurosciences, Inc. Modulators of acetylcholine receptors
US5705512A (en) 1994-11-10 1998-01-06 Sibia Neurosciences, Inc. Modulators of acetylcholine receptors
US5723477A (en) 1994-11-10 1998-03-03 Sibia Neurosciences, Inc. Modulators of acetylcholine receptors
US6057346A (en) 1994-12-12 2000-05-02 The United States Of America As Represented By The Department Of Health And Human Services Inhibition of retroviral LTR promoters by calcium response modifiers
US5521056A (en) 1995-01-10 1996-05-28 Eastman Kodak Company Photographic peracid bleaching composition and processing method using ternary iron carboxylate complexes as catalysts in peracid bleaching solutions
EP0751130A4 (fr) 1995-01-12 1998-07-08 Otsuka Kagaku Kk Derives de la 4,5-dihydropyrazole-5-thione et acaricide les contenant
US5656449A (en) 1995-03-06 1997-08-12 Molecular Probes, Inc. Neutral unsymmetrical cyanine dyes
JPH08337583A (ja) 1995-04-13 1996-12-24 Takeda Chem Ind Ltd 複素環化合物およびその製造法
GB9520355D0 (en) 1995-10-05 1995-12-06 Zeneca Ltd Chemical process
JPH11505815A (ja) 1995-05-23 1999-05-25 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ （２−モルホリニルメチル）ベンズアミン誘導体
US6015905A (en) 1995-06-28 2000-01-18 Zeneca Limited Process for the preparation of 2-(6-substituted pyrid-2-yloxymethyl) phenylacetate
AU7095496A (en) 1995-09-26 1997-04-17 Nippon Soda Co., Ltd. Pyrazole compounds, process for preparing the same, and agrohorticultural bactericide
WO1997016187A1 (fr) 1995-10-31 1997-05-09 Merck & Co., Inc. Antagoniste de la muscarine
WO1997016192A1 (fr) 1995-10-31 1997-05-09 Merck & Co., Inc. Antagoniste de la muscarine
US5756508A (en) 1995-10-31 1998-05-26 Merck & Co., Inc. Muscarine antagonists
GB9525296D0 (en) 1995-12-11 1996-02-07 Merck Sharp & Dohme Therapeutic agents
AU717744B2 (en) 1996-01-15 2000-03-30 Janssen Pharmaceutica N.V. Angiogenesis inhibiting pyridazinamines
GB9605331D0 (en) 1996-03-13 1996-05-15 Glaxo Group Ltd Chemical compounds
US5880137A (en) 1996-04-19 1999-03-09 American Home Products Corporation 2-phenyl-1- 4-(amino-1-yl-alk-1-ynyl)-benzyl!-1H-indol-5-ols as estrogenic agents
CA2253910A1 (fr) 1996-05-11 1997-11-20 King's College London Pyrazines
DE19620508A1 (de) 1996-05-22 1997-11-27 Hoechst Ag Schwefelenthaltende heterocyclische Bradykinin-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung
US5672592A (en) 1996-06-17 1997-09-30 Guilford Pharmaceuticals Inc. Certain phosphonomethyl-pentanedioic acid derivatives thereof
FR2751969B1 (fr) 1996-08-01 1998-12-04 Centre Nat Rech Scient Composes activateurs du canal cftr, et compositions pharmaceutiques les contenant
US6340682B1 (en) 1996-08-23 2002-01-22 Kowa Co., Ltd. Diamide compound and drugs containing the same
TW382127B (en) 1996-08-30 2000-02-11 Sony Corp Magnetic recording medium and cleaning tape
DE69707907T2 (de) 1996-09-26 2002-05-16 Syngenta Participations Ag, Basel Herbizid wirkende zusammensetzung
DE69724630T2 (de) 1996-10-02 2004-07-29 Bristol-Myers Squibb Pharma Co. 4,4-disubstituierte 1,4-dihydro-2h-3,1-benzoxazin-2-one die anwendbar sind als hiv-reverstranskriptase-inhibitoren, zwischenprodukte und verfahren zu ihrer herstellung
ATE234091T1 (de) 1996-10-24 2003-03-15 Merck & Co Inc Thrombin inhibitoren
US5869487A (en) 1996-10-24 1999-02-09 Merck & Co., Inc. Pyrido 3,4-B!pyrazines for use as thrombin inhibitors
US5965572A (en) 1996-10-28 1999-10-12 The United States Of America As Respresented By The Secretary Of The Army Methods for treating antibiotic-resistant infections
US6274598B1 (en) 1996-10-28 2001-08-14 The United States Of America As Represented By The Secretary Of The Army Methods for treating antibiotic-resistant infections
US20020115678A1 (en) 1996-10-28 2002-08-22 Ellis William Y. Compounds, compositions and methods for treating antibiotic-resistant infections
US6147080A (en) 1996-12-18 2000-11-14 Vertex Pharmaceuticals Incorporated Inhibitors of p38
JPH10188264A (ja) 1996-12-24 1998-07-21 Sony Corp 磁気記録媒体及びその製造方法
EP0961614A4 (fr) 1996-12-30 2002-07-24 Univ Bar Ilan Oxyalkylesters contenant de l'acide tricarboxylique et leurs utilisations
JP2001512460A (ja) 1997-02-18 2001-08-21 イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー 除草性テトラゾリノン類
JPH10324687A (ja) 1997-02-19 1998-12-08 Nippon Soda Co Ltd ピロール化合物、製法および農園芸用殺菌剤
US5811442A (en) 1997-02-21 1998-09-22 Bencherif; Merouane Pharmaceutical compositions for the treatment of conditions associated with decreased blood flow
DE19718742A1 (de) 1997-05-02 1998-11-05 Hoechst Ag Verfahren zur Herstellung von aromatischen Aldehyden durch katalytische Gasphasenhydrierung der Carbonsäuren
FR2763334A1 (fr) 1997-05-13 1998-11-20 Lipha Derives anthraniliques
FR2763588B1 (fr) 1997-05-23 1999-07-09 Cird Galderma Composes triaromatiques, compositions les contenant et utilisations
GB9711753D0 (en) 1997-06-06 1997-08-06 Merck Sharp & Dohme Therapeutic agents
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
AU757059B2 (en) 1997-06-19 2003-01-30 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
WO1999001453A1 (fr) 1997-07-02 1999-01-14 F. Hoffmann-La Roche Ag Procede de fabrication de derives de chromanylpyridine a activite optique
DE19728996A1 (de) 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
AU740447B2 (en) 1997-09-23 2001-11-01 Merck & Co., Inc. Thrombin inhibitors
WO1999027930A1 (fr) 1997-12-01 1999-06-10 Merck & Co., Inc. Inhibiteurs de thrombine
US7329670B1 (en) 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
IL136768A0 (en) 1997-12-22 2001-06-14 Bayer Ag INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
NZ505845A (en) 1997-12-22 2003-10-31 Bayer Ag Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US6632823B1 (en) 1997-12-22 2003-10-14 Merck & Co., Inc. Substituted pyridine compounds useful as modulators of acetylcholine receptors
WO1999033810A1 (fr) 1997-12-24 1999-07-08 Kumiai Chemical Industry Co., Ltd. Derives amides d'acide pyridyloxy(thio)alcanoique et bactericides a usage agricole ou horticole
DK0930302T3 (da) 1998-01-16 2003-07-21 Hoffmann La Roche Benzosulfonderivater
PL341984A1 (en) 1998-01-28 2001-05-07 Shionogi & Co Novel tricycle compounds
US7517884B2 (en) 1998-03-30 2009-04-14 Kalypsys Inc. Sulfonyl-substituted bicyclic compounds as modulators of PPAR
JPH11292883A (ja) 1998-04-07 1999-10-26 Yoshitomi Fine Chemical Kk トリフェニルボロンアミン付加化合物の製造方法
HUP0102052A3 (en) 1998-04-27 2002-10-28 Janssen Pharmaceutica Nv Pellets having a core coated with a lipid lowering agent and a polymer and process for their preparation
CN1133634C (zh) 1998-05-02 2004-01-07 阿斯特拉曾尼卡有限公司 抑制因子Xa的杂环衍生物
EP1085890A1 (fr) 1998-06-08 2001-03-28 Advanced Medicine, Inc. Nouveaux medicaments des canaux sodiques et utilisations
CO5090829A1 (es) 1998-07-21 2001-10-30 Novartis Ag Compuestos organicos de la formula i, utiles como inhibido res de la proteina de transferencia de triglicerido microso mal y de la secrecion de la apolipoproteina b.
US6197798B1 (en) 1998-07-21 2001-03-06 Novartis Ag Amino-benzocycloalkane derivatives
ES2192394T3 (es) 1998-08-10 2003-10-01 Winston Pharmateuticals Llc Profarmacos de inhibidores de la bomba de protones.
ES2342240T3 (es) 1998-08-11 2010-07-02 Novartis Ag Derivados de isoquinolina con actividad que inhibe la angiogenia.
JP2000073094A (ja) 1998-08-28 2000-03-07 Lion Corp カビ取り剤組成物
JP2000076640A (ja) 1998-08-31 2000-03-14 Sony Corp 磁気記録再生装置
JP2000076643A (ja) 1998-08-31 2000-03-14 Sony Corp 磁気ディスク装置
JP2000076642A (ja) 1998-08-31 2000-03-14 Sony Corp 磁気記録再生装置
EP1114030B1 (fr) 1998-09-15 2005-06-01 Syngenta Participations AG Pyridinecetones utilises comme herbicides
ATE349700T1 (de) 1998-10-27 2007-01-15 Molecular Probes Inc Übergangsmetallkomplex-haltige lumineszente proteinfarben
US6133031A (en) 1999-08-19 2000-10-17 Isis Pharmaceuticals Inc. Antisense inhibition of focal adhesion kinase expression
BR9916919A (pt) 1998-12-04 2002-01-15 Fujisawa Pharmaceutical Co Compósito de sulfonamida e seu uso
CA2350888A1 (fr) 1998-12-04 2000-06-15 John Anthony Butera Amino-cyclobut-3-ene-1,2-diones substitues en positions 4 et 3 et leur utilisation pour induire la contraction des muscles lisses
AR023071A1 (es) 1998-12-23 2002-09-04 Syngenta Participations Ag Compuestos de piridincetona, compuestos intermediarios, composicion herbicida e inhibidora del crecimiento de plantas, metodo para controlar la vegetacion indeseada, metodo para inhibir el crecimiento de las plantas, y uso de la composicion para controlar el crecimiento indeseado de plantas.
US20020103141A1 (en) 1998-12-23 2002-08-01 Mckearn John P. Antiangiogenic combination therapy for the treatment of cancer
GB9901253D0 (en) 1999-01-20 1999-03-10 Isis Innovation Bis-terpyridine-platinum(II) complexes
GB9905075D0 (en) 1999-03-06 1999-04-28 Zeneca Ltd Chemical compounds
DE19932571A1 (de) 1999-07-13 2001-01-18 Clariant Gmbh Verfahren zur Herstellung von Biarylen unter Palladophosphacyclobutan-Katalyse
US7122627B2 (en) 1999-07-26 2006-10-17 Bristol-Myers Squibb Company Lactam inhibitors of Hepatitis C virus NS3 protease
CA2376961A1 (fr) 1999-07-26 2001-02-01 Bristol-Myers Squibb Pharma Company Inhibiteurs lactame de la protease ns3 du virus de l'hepatite c
CN1384825A (zh) 1999-08-31 2002-12-11 马克西亚药品公司 亚苄基－噻唑烷二酮及其类似物以及它们在治疗糖尿病中的应用
JP2001072660A (ja) 1999-09-08 2001-03-21 Welfide Corp ＴＮＦ−α産生抑制剤および／またはＩＬ−１０産生促進剤
JP4523093B2 (ja) 1999-09-20 2010-08-11 広栄化学工業株式会社 ２−アミノ−ブロモピラジン類の製造方法
AU1053501A (en) 1999-11-02 2001-05-14 Ajinomoto Co., Inc. Polyazanaphthalene compound and medicinal use thereof
BR0015671A (pt) 1999-11-18 2002-07-23 Novartis Ag Compostos de aminoheterociclamida pesticidal
AU779230C (en) 1999-12-03 2006-05-25 Emory University Curcumin analogues for treating cancer
GB0004890D0 (en) 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
JP4388189B2 (ja) 2000-03-08 2009-12-24 独立行政法人科学技術振興機構 ピリジン誘導体及びその製造方法
US6768008B2 (en) 2000-04-24 2004-07-27 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
EP1276730A2 (fr) 2000-04-24 2003-01-22 ARYx Therapeutics Compositions et methodes destinees au traitement du diabete, de l'hyperlipidemie, de l'hypercholesterolemie et de l'atherosclerose
US20040034225A1 (en) 2000-05-17 2004-02-19 Jacqueline Marchand-Brynaert Aryl-substituted n, n-heterocyclic compounds, method for their preparationand their use in therapeutics and diagnostics
EP1294358B1 (fr) 2000-06-28 2004-08-18 Smithkline Beecham Plc Procede de broyage par voie humide
EP1295880A4 (fr) 2000-06-28 2004-05-06 Ssp Co Ltd Derives imidazole ou sels de ces derniers, et medicaments contenant les derives ou les sels
WO2002006271A1 (fr) 2000-07-19 2002-01-24 F. Hoffmann-La Roche Ag Derives de pyrimidine
US6541639B2 (en) 2000-07-26 2003-04-01 Bristol-Myers Squibb Pharma Company Efficient ligand-mediated Ullmann coupling of anilines and azoles
JP2004505060A (ja) 2000-07-27 2004-02-19 ファルマシア・コーポレーション 炎症関連心臓血管障害を防止するかまたは治療するためのアルドステロンアンタゴニストおよびシクロオキシゲナーゼ−２阻害剤併用療法
JO2654B1 (en) 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
AU2001294673A1 (en) 2000-09-21 2002-04-02 Aryx Therapeutics Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, andatherosclerosis
US6727361B2 (en) 2000-11-07 2004-04-27 Symyx Technologies, Inc. Phosphino substituted pyridine amine ligands
CA2430037A1 (fr) 2000-11-20 2002-05-30 Michael S. South Aryl-et-heteroaryl-pyridines polycycliques substituees utiles dans l'inhibition selective de la cascade de la coagulation
FR2816942B1 (fr) 2000-11-23 2003-05-09 Sanofi Synthelabo Derives de benzimidazole, leur preparation et leur application en therapeutique
DE10060807A1 (de) 2000-12-07 2002-06-20 Aventis Pharma Gmbh Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
US6610723B2 (en) 2001-01-29 2003-08-26 Hoffmann-La Roche Inc. Imidazole derivatives
KR100844062B1 (ko) 2001-02-21 2008-07-07 미쓰이 가가쿠 가부시키가이샤 올레핀 중합용 촉매 및 이 촉매를 사용하는 올레핀중합체의 제조방법
MXPA03007864A (es) 2001-03-02 2003-12-04 Hoffmann La Roche Derivados del acido alcoxicarbonilamino-heteroaril carboxilico como antagonistas ip.
FR2821718B1 (fr) 2001-03-08 2003-06-13 Aventis Cropscience Sa Nouvelles compositions fongicides a base de derives de pyridylmethylbenzamide et d'imidazoline ou d'oxazolidine
JP2004523571A (ja) 2001-03-08 2004-08-05 マキシア・ファーマシューティカルズ・インコーポレイテッド Ｒｘｒ活性化分子
US7012098B2 (en) 2001-03-23 2006-03-14 Pharmacia Corporation Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers
EE200300469A (et) 2001-03-28 2004-02-16 Pfizer Inc. N-fenpropüültsüklopentüülasendatud glutaramiidi derivaadid kui NEP inhibiitorid FSAD puhul
CA2446380A1 (fr) 2001-05-08 2002-11-14 Yale University Composes proteomimetiques et procedes correspondants
JP2002338537A (ja) 2001-05-16 2002-11-27 Mitsubishi Pharma Corp アミド化合物およびその医薬用途
JP2002338837A (ja) 2001-05-16 2002-11-27 Fuji Photo Film Co Ltd 新規化合物、色素、インク組成物、インクジェット用インク、インクジェット記録方法、及び熱転写色素
JP4026768B2 (ja) 2001-06-08 2007-12-26 日本たばこ産業株式会社 流動体の塗布装置及びその塗布ノズル
JP4180254B2 (ja) 2001-06-29 2008-11-12 独立行政法人科学技術振興機構 窒素含有６員環の製造方法
SE0102438D0 (sv) 2001-07-05 2001-07-05 Astrazeneca Ab New compounds
JP4340404B2 (ja) 2001-07-23 2009-10-07 独立行政法人科学技術振興機構 不飽和６員環の製造方法
US20040235877A1 (en) 2001-09-14 2004-11-25 Natsuki Ishizuka Novel use of tricyclic compound
JP4339881B2 (ja) 2001-09-19 2009-10-07 ソフトバンクモバイル株式会社 ベアラ選択方法および移動通信端末
CN100391958C (zh) 2001-09-19 2008-06-04 安万特医药股份有限公司 化合物
FR2830194B1 (fr) 2001-09-28 2003-12-19 Oreal Composition contenant un derive de pyrazine et utilisation pour la teinture directe ou d'oxydation et/ou l'eclaircissement optique des fibres keratiniques
FR2831022B1 (fr) 2001-10-23 2004-01-23 Aventis Cropscience Sa Composition fongicide a base d'au moins un derive de pyridylmethylbenzamide et d'au moins un derive dithiocarbamate
PT1441737E (pt) 2001-10-30 2006-12-29 Dana Farber Cancer Inst Inc Derivados de estrutura como inibidores da actividade do receptor de tirosina cinase flt3
US7166368B2 (en) 2001-11-07 2007-01-23 E. I. Du Pont De Nemours And Company Electroluminescent platinum compounds and devices made with such compounds
US7361671B2 (en) 2001-11-15 2008-04-22 The Institute For Pharmaceutical Discovery, Inc. Substituted heteroarylalkanoic acids
JP4416998B2 (ja) 2001-11-19 2010-02-17 日本エンバイロケミカルズ株式会社 微生物防除剤
DE10238113A1 (de) 2001-12-11 2003-06-18 Bayer Ag Substituierte 2-Thio-3,5-dicyano-4-phenyl-6-aminopyridine und ihre Verwendung
US7091357B2 (en) 2001-12-26 2006-08-15 University Of Kentucky Research Foundation Chain-modified pyridino-N substituted nicotine compounds for use in the treatment of CNS pathologies
JP2005162612A (ja) 2002-01-09 2005-06-23 Ajinomoto Co Inc アシルスルホンアミド誘導体
CA2471566A1 (fr) 2002-01-10 2003-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Combinaison d'inhibiteurs de mtp ou d'inhibiteurs de secretions apob avec des fibrates en vue d'une utilisation comme medicament
EP1467733A1 (fr) 2002-01-11 2004-10-20 Eli Lilly And Company Derives d'ethanolamine a substitution de 2-oxo-benzimidazolyle, et leur utilisation comme beta3 agonistes
EP1470108B1 (fr) 2002-01-18 2016-08-24 Vittal Mallya Scientific Research Foundation Composes de pyridine et de 1,4-dihydropyridine en tant que bloqueurs de canaux calciques
EP1467981A1 (fr) 2002-01-25 2004-10-20 Kylix Pharmaceuticals B.V. (thia-/oxa-/pyra) zoles substitues 4(hetero-) aryle pour inhibition de tie-2
EP1476428B1 (fr) 2002-02-22 2010-11-17 Pharmacia & Upjohn Company LLC Derives de pyridyl sulfone utilises comme ligands du recepteur 5-ht6
US6929747B2 (en) 2002-02-28 2005-08-16 Renesselaer Polytechnic Institute High-affinity, low-molecular-mass displacers for ion-exchange chromatography
US20090011991A1 (en) 2002-03-08 2009-01-08 Emory University Novel Curcuminoid-Factor VIIA Constructs as Suppressors of Tumor Growth and Angiogenesis
US20050069551A1 (en) 2002-03-08 2005-03-31 Emory University Cytotoxic compound-protein conjugates as suppressors of tumor growth and angiogenesis
US20040127719A1 (en) 2002-03-08 2004-07-01 Kexin Yang Alpha-isocyanocarboxylate solid support templates, method of preparation and for using the same
CN1374306A (zh) 2002-03-27 2002-10-16 江苏省农药研究所 改良的杀虫剂中间体制备方法
JP2005320249A (ja) 2002-05-01 2005-11-17 Banyu Pharmaceut Co Ltd ２−アミノピラジン誘導体の製造方法
US20060089400A1 (en) 2002-05-03 2006-04-27 The Vernalis Group Of Companies Novel spiro ketone and carboxylic acid derivatives as specific inhibitors for (po3h2) ser/(po3h2)thr-pro-specific peptidyl-prolylcis/trans-isomerases
US6806265B2 (en) 2002-05-16 2004-10-19 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
PE20040522A1 (es) 2002-05-29 2004-09-28 Novartis Ag Derivados de diarilurea dependientes de la cinasa de proteina
US6770763B2 (en) 2002-06-11 2004-08-03 Bristol-Myers Squibb Company Asymmetric synthesis of amino-pyrrolidinones
GB0215676D0 (en) 2002-07-05 2002-08-14 Novartis Ag Organic compounds
JP4178008B2 (ja) 2002-08-02 2008-11-12 日本エンバイロケミカルズ株式会社 藻類防除剤および藻類防除方法
KR20050059051A (ko) 2002-08-02 2005-06-17 파마시아 코포레이션 위장 증상의 치료 및 예방 방법
JP2003292408A (ja) 2002-08-13 2003-10-15 Takeda Chem Ind Ltd 微生物防除剤
SE0202429D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab Novel Compounds
WO2004017920A2 (fr) 2002-08-23 2004-03-04 University Of Connecticut Nouveaux cannabinoides biphenyle et de type biphenyle
WO2004019863A2 (fr) 2002-08-28 2004-03-11 Intermune, Inc. Therapie de combinaison pour le traitement de troubles fibrosants
JP4513569B2 (ja) 2002-08-29 2010-07-28 日本ゼオン株式会社 遷移金属化合物、共役ジエン重合用触媒、共役ジエン重合体の製造方法、ならびにポリイソプレンとその環化物およびそれらの製造方法
JP4566540B2 (ja) 2002-10-03 2010-10-20 日本エンバイロケミカルズ株式会社 工業用殺菌剤、塗料、インク、樹脂エマルション、金属加工油剤、湿し水
JP2004123617A (ja) 2002-10-03 2004-04-22 Japan Enviro Chemicals Ltd 微生物防除剤
US20070066619A1 (en) 2002-10-07 2007-03-22 Artesian Therapeutics, Inc. Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity
EP1554267A1 (fr) 2002-10-07 2005-07-20 Artesian Therapeutics, Inc. Composes de dihydropyridine presentant a la fois la capacite de bloquer des canaux calciques de type l et la capacite d'inhiber l'activite de type 3 de la phosphodiesterase
JP3587839B2 (ja) 2002-10-23 2004-11-10 日本エンバイロケミカルズ株式会社 ビス四級アンモニウム塩化合物の安定化方法
US20040082641A1 (en) 2002-10-28 2004-04-29 Rytved Klaus Asger Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseases
FR2846657B1 (fr) 2002-11-05 2004-12-24 Servier Lab Nouveaux composes pyridopyrimidinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ITMI20022389A1 (it) 2002-11-12 2004-05-13 Nicox Sa Farmaci per le disfunzioni sessuali.
AR042052A1 (es) 2002-11-15 2005-06-08 Vertex Pharma Diaminotriazoles utiles como inhibidores de proteinquinasas
DE10254596A1 (de) 2002-11-22 2004-06-03 Merck Patent Gmbh Indolderivate
US7135472B2 (en) 2002-11-22 2006-11-14 Bristol-Myers Squibb Company 3-Heterocyclic benzylamide derivatives as potassium channel openers
PT1575951E (pt) 2002-12-06 2014-09-15 Debiopharm Int Sa Compostos heterocíclicos, métodos para os preparar e sua utilização em terapia
AU2003296414A1 (en) 2002-12-12 2004-07-09 Pharmacia Corporation Method of using aminocyanopyridine compounds as mitogen activated protein kinase-activated protein kinase-2 inhibitors
US20040142978A1 (en) 2002-12-12 2004-07-22 Pharmacia Corporation Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
US20040127519A1 (en) 2002-12-12 2004-07-01 Pharmacia Corporation Method of using aminocyanopyridine compounds as mitogen activated protein kinase-activated protein kinase-2 inhibitors
JP4473503B2 (ja) 2002-12-16 2010-06-02 日本エンバイロケミカルズ株式会社 微生物防除剤
SE0203752D0 (sv) 2002-12-17 2002-12-17 Astrazeneca Ab New compounds
UA80767C2 (en) 2002-12-20 2007-10-25 Pfizer Prod Inc Pyrimidine derivatives for the treatment of abnormal cell growth
ES2215474B1 (es) 2002-12-24 2005-12-16 J. URIACH & CIA S.A. Nuevos derivados de fosforamida.
JP3502629B1 (ja) 2002-12-26 2004-03-02 日本エンバイロケミカルズ株式会社 微生物防除剤および安定化方法
GB0300783D0 (en) 2003-01-14 2003-02-12 Btg Int Ltd Treatment of neurodegenerative conditions
GB0301350D0 (en) 2003-01-21 2003-02-19 Merck Sharp & Dohme Therapeutic agents
TW200418791A (en) 2003-01-23 2004-10-01 Bristol Myers Squibb Co Pharmaceutical compositions for inhibiting proteasome
WO2004069160A2 (fr) 2003-01-28 2004-08-19 Smithkline Beecham Corporation Composes chimiques
PE20040945A1 (es) 2003-02-05 2004-12-14 Warner Lambert Co Preparacion de quinazolinas substituidas
US20060160864A1 (en) 2003-02-07 2006-07-20 Mitsuru Shiraishi Acrylamide derivative, process for producing the same, and use
WO2004069805A1 (fr) 2003-02-10 2004-08-19 Bayer Healthcare Ag Derives de bis(hetero)aryle carboxamide destines a etre utilises en tant qu'antagonistes de la pg12
GB0305929D0 (en) 2003-03-14 2003-04-23 Novartis Ag Organic compounds
DE10315573A1 (de) 2003-04-05 2004-10-14 Merck Patent Gmbh Substituierte Pyrazole
US7129264B2 (en) 2003-04-16 2006-10-31 Bristol-Myers Squibb Company Biarylmethyl indolines and indoles as antithromboembolic agents
CA2464604A1 (fr) 2003-04-17 2004-10-17 Queen's University At Kingston Produits luminescents organiques et methodes de fabrication et d'utilisation connexes
DE10318611A1 (de) 2003-04-24 2004-11-11 Elbion Ag 4-, 6- oder 7-Hydroxyindole mit N-Oxidgruppen und deren Verwendung als Therapeutika
DE10318609A1 (de) 2003-04-24 2004-11-11 Elbion Ag 5-Hydroxyindole mit N-Oxidgruppen und deren Verwendung als Therapeutika
DE10318610A1 (de) 2003-04-24 2004-11-11 Elbion Ag 7-Azaindole und deren Verwendung als Therapeutika
EP1837330B1 (fr) 2003-05-12 2012-10-24 Pfizer Products Inc. Inhibiteurs benzamidiques du recepteur P2X7
GB0311081D0 (en) 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
WO2004104052A1 (fr) 2003-05-21 2004-12-02 Basell Polyolefine Gmbh Complexes metalliques de transition comprenant des ligands tridentates contenant de l'azote
AU2003902860A0 (en) 2003-06-06 2003-06-26 Daicel Chemical Industries, Ltd Benzimidazole compounds
CA2526506A1 (fr) 2003-06-09 2004-12-16 Boehringer Ingelheim International Gmbh Inhibiteurs du papillomavirus
WO2004113258A1 (fr) 2003-06-20 2004-12-29 Shionogi & Co., Ltd. Reaction formant une liaison carbone carbone
AU2004249529A1 (en) 2003-06-23 2004-12-29 Bellus Health (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
WO2005000309A2 (fr) 2003-06-27 2005-01-06 Ionix Pharmaceuticals Limited Composes chimiques
WO2005005382A2 (fr) 2003-07-02 2005-01-20 Cytokinetics, Inc. Composes, compositions et procedes associes
JP4363098B2 (ja) 2003-07-11 2009-11-11 三菱化学株式会社 ビスイミダゾピラジノン誘導体及びビスアミノピラジン誘導体
WO2005025623A2 (fr) 2003-07-28 2005-03-24 Emory University Conjugues compose cytotoxique-proteine utilises en tant que suppresseurs de croissance tumorale et d'angiogenese
JP2005058997A (ja) 2003-07-30 2005-03-10 Mitsubishi Motors Corp 排気浄化触媒装置
JP2007500178A (ja) 2003-07-30 2007-01-11 サイクラセル・リミテッド プロテインキナーゼ阻害剤としてのピリジニルアミノ−ピリミジン誘導体
US7198730B2 (en) 2003-08-28 2007-04-03 E. I. Du Pont De Nemours And Company Phosphorescent material
US7504401B2 (en) 2003-08-29 2009-03-17 Locus Pharmaceuticals, Inc. Anti-cancer agents and uses thereof
WO2005026166A1 (fr) 2003-09-16 2005-03-24 'chemical Diversity Research Institute', Ltd. Composition physiologiquement active, composition pharmaceutique, 1,2-dihydro[2,7]naphtyridine, procedes de fabrication et application
SI1664041T1 (sl) 2003-09-22 2008-12-31 Euro Celtique Sa Fenil-karboksamidne spojine, uporabne za tretiranje bolečine
PE20050952A1 (es) 2003-09-24 2005-12-19 Novartis Ag Derivados de isoquinolina como inhibidores de b-raf
JP2005126586A (ja) 2003-10-24 2005-05-19 Konica Minolta Holdings Inc ポリメチン色素、光電変換材料用半導体、光電変換素子及び太陽電池
US7786314B2 (en) 2003-11-07 2010-08-31 Taisho Pharmaceutical Co., Ltd Processes for preparing bicyclo [3.1.0] hexane derivatives, and intermediates thereto
FR2862304A1 (fr) 2003-11-14 2005-05-20 Centre Nat Rech Scient Molecules duales racemiques ou achirales contenant un derive peroxydique, leur synthese et leurs applications therapeutiques
SE0303180D0 (sv) 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
WO2005058876A1 (fr) 2003-12-16 2005-06-30 Gpc Biotech Ag Derives de la pyrazine utilises en tant que composes efficaces contre les maladies infectieuses
WO2005066162A1 (fr) 2003-12-23 2005-07-21 Human Biomolecular Research Institute Composes synthetiques et derives de ceux-ci en tant que modulateurs de fumee ou d'ingestion de nicotine et du cancer du poumon
KR20060125885A (ko) 2004-02-04 2006-12-06 뉴로서치 에이/에스 콜린 수용체 조절제로서의 디아자바이사이클릭 아릴 유도체
DE102004005785A1 (de) 2004-02-06 2005-08-25 Bayer Cropscience Ag 2-Halogenfuryl/thienyl-3-carboxamide
EP1715867A4 (fr) 2004-02-12 2009-04-15 Merck & Co Inc Amides bipyridyles en tant que modulateurs du r cepteur-5 metabotropique du glutamate
US7378448B2 (en) 2004-03-15 2008-05-27 Eli Lilly And Company Diphenylether amide derivatives as opioid receptor antagonists
US7596407B2 (en) 2004-03-26 2009-09-29 Solvay Pharmaceuticals, B.V. Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds
JP4790703B2 (ja) 2004-04-07 2011-10-12 武田薬品工業株式会社 環式化合物
AR048523A1 (es) 2004-04-07 2006-05-03 Kalypsys Inc Compuestos con estructura de aril sulfonamida y sulfonilo como moduladores de ppar y metodos para tratar trastornos metabolicos
US20050239826A1 (en) 2004-04-14 2005-10-27 Boehringer Ingelheim International Gmbh Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
MY143245A (en) 2004-04-28 2011-04-15 Mitsubishi Tanabe Pharma Corp 4- 2-(cycloalkylamino)pyrimidin-4-yl-(phenyl)-imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases
TWI355380B (en) 2004-05-27 2012-01-01 Nihon Nohyaku Co Ltd Substituted pyrazinecarboxanilide derivatives or s
MXPA06014247A (es) 2004-06-10 2007-03-12 Irm Llc Compuestos y composiciones como inhibidores de la proteina quinasa.
CA2578600A1 (fr) 2004-06-16 2006-01-26 Wyeth Diphenylimidazopyrimidine et -imidazole amines utilisees comme inhibiteurs de b-secretase
JP4413087B2 (ja) 2004-06-16 2010-02-10 新日本製鐵株式会社 スラグ砕石の製造方法
CA2579724A1 (fr) 2004-06-16 2006-01-26 Wyeth Derives d'amino-5,5-diphenylimidazolone servant a inhiber la beta-secretase
JP2008504372A (ja) 2004-06-18 2008-02-14 ニューロケム （インターナショナル） リミティッド β−アミロイド関連疾患の治療のための治療用製剤
DE102004032651A1 (de) 2004-07-06 2006-02-16 Bayer Healthcare Ag Verwendung von substituierten 2-Thio-3,5-dicyano-4-phenyl-6-aminopyriden bei der Behandlung von Übelkeit und Erbrechen
JP5050312B2 (ja) 2004-07-23 2012-10-17 コニカミノルタホールディングス株式会社 有機エレクトロルミネッセンス素子、表示装置及び照明装置
EP1789041B1 (fr) 2004-07-28 2008-07-09 F. Hoffmann-Roche AG Derives d'aryl-pyridine comme inhibiteurs de la 11-beta-h5d1
WO2006038606A1 (fr) 2004-10-05 2006-04-13 Shionogi & Co., Ltd. Dérivé de biaryle
CA2584794A1 (fr) 2004-10-26 2006-05-04 Third-Order Nanotechnologies, Inc. Systemes d'espacement tricycliques pour dispositifs optiques non lineaires
RU2384576C2 (ru) 2004-10-29 2010-03-20 Калипсис, Инк Сульфонил-замещенные бициклические соединения в качестве модуляторов ppar
EP1820504A1 (fr) 2004-11-15 2007-08-22 Taisho Pharmaceutical Co., Ltd Composé imine
JPWO2006051937A1 (ja) 2004-11-15 2008-05-29 塩野義製薬株式会社 ヘテロ５員環誘導体
JP2008520693A (ja) 2004-11-18 2008-06-19 ジ インスチチュート フォー ファーマシューティカル ディスカバリー、エルエルシー プロテインチロシンホスファターゼ阻害剤としての置換アミノ酸
AP2007003980A0 (en) 2004-11-23 2007-06-30 Pfizer Prod Inc Dibenzylamine compounds and derivatives
RU2007123675A (ru) 2004-11-24 2008-12-27 Новартис АГ (CH) Комбинации ингибиторов jak
WO2006060762A2 (fr) 2004-12-03 2006-06-08 Arena Pharmaceuticals, Inc. Derives de pyrazole en tant que modulateurs du recepteur de serotinine 5-ht2a utiles dans le traitement de troubles associes a ce recepteur
CA2591738A1 (fr) 2004-12-22 2006-06-29 Merck & Co., Inc. Procedes de production de piperidines substituees
US7968574B2 (en) 2004-12-28 2011-06-28 Kinex Pharmaceuticals, Llc Biaryl compositions and methods for modulating a kinase cascade
MX2007008008A (es) 2004-12-30 2007-11-12 Astex Therapeutics Ltd Compuestos de pirazol que modulan la actividad de las cinasas cdk, gsk y aurora.
EP1844003A4 (fr) 2005-01-27 2010-09-22 Astrazeneca Ab Nouveaux composes biaromatiques, inhibiteurs du recepteur p2x7
WO2006082001A1 (fr) 2005-02-07 2006-08-10 F.Hoffmann-La Roche Ag Phenylmethanones heterocycliques substituees servant d’inhibiteurs du transporteur 1 de la glycine
WO2006084773A1 (fr) 2005-02-11 2006-08-17 Bayer Cropscience Sa Composition fongicide comprenant un derive du pyridylmethylbenzamide et un derive du thiazolecarboxamide
CN101189238A (zh) 2005-02-16 2008-05-28 先灵公司 具有cxcr3拮抗剂活性的哌嗪-哌啶
WO2006103254A1 (fr) 2005-04-01 2006-10-05 Clariant International Ltd Betaines d'acide squarique pour couches optiques en enregistrement optique de donnees
US7820699B2 (en) 2005-04-27 2010-10-26 Hoffmann-La Roche Inc. Cyclic amines
WO2006124874A2 (fr) 2005-05-12 2006-11-23 Kalypsys, Inc. Inhibiteurs de la b-raf kinase
DE102005025315A1 (de) 2005-06-02 2006-12-14 Merck Patent Gmbh Ionische Flüssigkeiten mit niedriger Viskosität
US7312331B2 (en) 2005-06-17 2007-12-25 The Regents Of The University Of California Stable cyclic (alkyl)(amino) carbenes as ligands for transition metal catalysts
DE102005030400A1 (de) 2005-06-27 2006-12-28 Archimica Gmbh Verfahren zur Herstellung von Arylaminen, Arylethern und Arylthioethern
DE102005032332A1 (de) 2005-07-08 2007-01-11 Merck Patent Gmbh Metallkomplexe
JP2009501721A (ja) 2005-07-12 2009-01-22 アカディア ファーマシューティカルズ インコーポレイテッド レチノイン酸受容体における活性を伴う化合物
WO2007011721A1 (fr) 2005-07-15 2007-01-25 Kalypsys, Inc. Inhibiteurs de kinesine mitotique
CN100562514C (zh) 2005-07-22 2009-11-25 中国科学院上海药物研究所 一类取代丙酰胺衍生物、其制备方法和用途
BRPI0614262A2 (pt) 2005-08-02 2011-03-15 Lexicon Pharmaceuticals Inc aril piridinas e métodos para uso das mesmas
JP4799073B2 (ja) 2005-08-04 2011-10-19 日本エンバイロケミカルズ株式会社 微生物防除剤
KR100696636B1 (ko) 2005-08-18 2007-03-19 삼성에스디아이 주식회사 염료감응 태양 전지용 염료 및 이로부터 제조된 염료감응태양 전지
CA2618770A1 (fr) 2005-08-25 2007-03-01 Emory University Inhibiteurs de hif
ZA200801822B (en) 2005-08-26 2009-09-30 Serono Lab Pyrazine derivatives and use as p13k inhibitors
US8044173B2 (en) 2005-09-13 2011-10-25 University Of Reading Asymmetric synthesis of peptides
US20090215857A1 (en) 2005-09-13 2009-08-27 Pfizer Products Inc. Therapeutic Pyrrolidines
US7732613B2 (en) 2005-09-14 2010-06-08 Bristol-Myers Squibb Company Met kinase inhibitors
DE102005045132A1 (de) 2005-09-22 2007-03-29 Archimica Gmbh Verfahren zur Herstellung von 2-Arylcarbonylverbindungen, 2-Arylestern und 2-Arylnitrilen sowie ihrer heteroaromatischen Analoga
EP1996550A2 (fr) 2005-09-27 2008-12-03 Novartis AG Composes carboxamines et leur utilisation pour le traitement de maladies liees a la hdac
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
JP2007145819A (ja) 2005-10-28 2007-06-14 Tanabe Seiyaku Co Ltd 医薬組成物
TW200732320A (en) 2005-10-31 2007-09-01 Biolipox Ab Pyrazoles useful in the treatment of inflammation
TW200734304A (en) 2005-11-08 2007-09-16 Astellas Pharma Inc Benzene derivative or salt thereof
US7531008B2 (en) 2005-11-30 2009-05-12 L'oreal S.A. Use of at least one cationic cyanin derivative for dyeing the hair, composition containing it, process for treating keratin fibers using the composition, and device therefor
EA014906B1 (ru) 2005-12-01 2011-02-28 Элан Фармасьютикалз, Инк. 5-(арилсульфонил)пиразолопиперидины
WO2007063935A1 (fr) 2005-12-02 2007-06-07 Mitsubishi Tanabe Pharma Corporation Compose aromatique
JP2007161674A (ja) 2005-12-16 2007-06-28 Tanabe Seiyaku Co Ltd ピペリジン化合物およびその製法
WO2007073855A1 (fr) 2005-12-23 2007-07-05 Bayer Healthcare Ag Utilisation d’agonistes des recepteurs a1 de l’adenosine en vue de proteger les cellules renales contre les effets toxiques induits par des aminoglycosides au cours du traitement de maladies infectieuses
US7855291B2 (en) 2005-12-29 2010-12-21 Lexicon Pharmaceuticals, Inc. Process for the preparation of substituted phenylalanines
JP5474354B2 (ja) 2005-12-30 2014-04-16 アステックス、セラピューティックス、リミテッド 医薬化合物
DE102006000651A1 (de) 2006-01-03 2007-07-12 Degussa Gmbh Präparation aus Ionischen Flüssigkeiten und Harzen
DE102006000649A1 (de) 2006-01-03 2007-07-05 Degussa Gmbh Universell einsetzbare Zusammensetzungen
FR2896798A1 (fr) 2006-01-27 2007-08-03 Sanofi Aventis Sa Derives de sulfonamides, leur preparation et leur application en therapeutique
HUP0600101A2 (en) 2006-02-09 2007-09-28 Univ Szegedi Resolution process for the preparation of cyclic beta-amino acids esters there of
US8227093B2 (en) 2006-02-11 2012-07-24 Samsung Mobile Display Co., Ltd. Cyclometalated transition metal complex and organic electroluminescence device using the same
CN101384586A (zh) * 2006-02-14 2009-03-11 诺华公司 Pi-3激酶抑制剂及其应用方法
DE102006009813A1 (de) 2006-03-01 2007-09-06 Bayer Healthcare Ag Verwendung von A2b/A1 Rezeptor Agonisten zur Modulation der Lipidspiegel
PE20071144A1 (es) 2006-03-21 2008-01-10 Schering Corp COMPUESTOS HETEROCICLICOS DE PIRIDINA SUSTITUIDA COMO ANTAGONISTAS DEL RECEPTOR 3 DE a-QUIMIOCINA (CXCR3)
WO2007107543A1 (fr) 2006-03-22 2007-09-27 Janssen Pharmaceutica N.V. Inhibiteurs de l'interaction entre mdm2 et p53
KR20090007347A (ko) 2006-03-22 2009-01-16 버텍스 파마슈티칼스 인코포레이티드 증식성 장애의 치료를 위한 ｃ-ＭＥＴ 단백질 키나제 억제제
WO2007112347A1 (fr) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Inhibiteurs de la dipeptidyl peptidase
ATE498619T1 (de) 2006-04-03 2011-03-15 Glaxo Group Ltd Azabicycloä3.1.0ühexanderivate als modulatoren von dopamin-d3-rezeptoren
US7759352B2 (en) 2006-04-14 2010-07-20 Merck Sharp & Dohme Corp. Substituted imidazole-4-carboxamides as cholecystokinin-1 receptor modulators
EP2010519B1 (fr) 2006-04-14 2011-07-06 Merck Sharp & Dohme Corp. Imidazole 4-carboxamides substitués comme modulateurs des récepteurs de cholécystokinine 1
CN101058577A (zh) 2006-04-18 2007-10-24 中国科学院化学研究所 1,4－二氢吡啶类化合物及其制备方法
CN101636154B (zh) 2006-04-27 2011-12-14 塞诺菲-安万特德国有限公司 Task-1和task-3离子通道抑制剂
EP2010523A1 (fr) 2006-04-27 2009-01-07 Glaxo Group Limited Composés spiro utiles en tant que modulateurs de récepteurs de la dopamine d3
JP5212985B2 (ja) 2006-05-02 2013-06-19 国立大学法人名古屋大学 不斉触媒作用用キラル四座配位子並びにその使用
ITMI20060895A1 (it) 2006-05-08 2007-11-09 Kemon S P A Intermedi primari per la colorazione ossidativa dei capelli
DE102006025316A1 (de) 2006-05-31 2007-12-06 Bayer Healthcare Ag Isoindolin-1-on-, Isoindolin-3-on- und Isoindolin-1,3-dion-Derivate und ihre Verwendung
DE602007004618D1 (de) 2006-06-22 2010-03-18 Biovitrum Ab Publ Pyridin- und pyrazinderivate als mnk-kinaseinhibitoren
US9216963B2 (en) 2006-06-22 2015-12-22 Medibeacon Inc. Pyrazine derivatives with extended conjugation and methods of using the same in optical applications
US20080280891A1 (en) 2006-06-27 2008-11-13 Locus Pharmaceuticals, Inc. Anti-cancer agents and uses thereof
JP5564251B2 (ja) 2006-06-29 2014-07-30 キネックス ファーマシューティカルズ， エルエルシー キナーゼカスケードを調節するためのビアリール組成物および方法
ES2500165T3 (es) 2006-06-29 2014-09-30 Kinex Pharmaceuticals, Llc Composiciones de biarilo y métodos para modular una cascada de quinasas
ES2645095T3 (es) 2006-06-30 2017-12-04 Sloan-Kettering Institute For Cancer Research Tratamiento de enfermedades neurodegenerativas a través de la inhibición de Hsp90
CN101511815A (zh) 2006-07-04 2009-08-19 阿斯利康(瑞典)有限公司 新型吡啶类似物
EP2054405B1 (fr) 2006-07-11 2013-09-18 Daewoong Pharmaceutical Co., Ltd. Nouveaux dérivés de biaryle benzoimidazole et composition pharmaceutique comprenant ces derniers
AR061975A1 (es) 2006-07-14 2008-08-10 Schering Corp Compuestos de piperazina 1,4-sustituida con actividad antagonista de cxcr3, una composicion farmaceutica que los comprende y su uso en el tratamiento de enfermedades mediadas por el receptor de quimioquina cxcr3
ITMI20061368A1 (it) 2006-07-14 2008-01-15 Acraf Composto 2-arilindolico sostituito in posizione 5, composizione farmaceutica che lo comprende nonche' composti intermedi e procedimento per prepararlo
CN101522623B (zh) 2006-08-03 2013-06-12 塔夫茨大学信托人 无潮红烟酸类似物和其使用方法
EP1900727A1 (fr) 2006-08-30 2008-03-19 Cellzome Ag Derivés d'aminopyridine en tant qu'inhibiteurs de kinases
KR20090057032A (ko) 2006-09-21 2009-06-03 노파르티스 아게 사이토카인 매개 질환의 치료에 유용한 피롤 유도체
KR100932093B1 (ko) 2006-09-27 2009-12-16 주식회사종근당 미세소관 형성 저해제로서 유용한 벤조페논 유도체
GB0619342D0 (en) 2006-09-30 2006-11-08 Vernalis R&D Ltd New chemical compounds
WO2008044713A1 (fr) 2006-10-10 2008-04-17 Nihon Nohyaku Co., Ltd. Dérivé de pyridinecarboxanilide substitué ou un de ses sels, agent agricole ou horticole et utilisation de celui-ci
DE102006048042A1 (de) 2006-10-11 2008-04-17 Bayer Healthcare Ag Acylaminoimidazole und Acylaminothiazole
DE102006048924A1 (de) 2006-10-17 2008-04-24 Bayer Healthcare Ag Acylaminopyrazole
US7820605B2 (en) 2006-10-27 2010-10-26 Chevron Oronite Company Llc Lubricating oil additive composition and method of making the same
US20090318410A1 (en) 2006-10-30 2009-12-24 Novartis Ag Imidazopyridazines as lipid kinase inhibitors
KR101146875B1 (ko) 2006-11-01 2012-05-16 에스케이이노베이션 주식회사 전이금속 촉매계 및 이를 이용한 에틸렌 단독중합체 또는에틸렌과 올레핀의 공중합체 제조방법
JP2009023986A (ja) 2006-11-08 2009-02-05 Pharma Ip 抗癌剤としてのビアリール誘導体
AU2007332143B2 (en) 2006-12-11 2012-11-08 Bionomics Limited Chemical compounds and processes
KR20090092317A (ko) 2006-12-11 2009-08-31 아이알엠 엘엘씨 키나제 억제제로서의 화합물 및 조성물
GB0624689D0 (en) 2006-12-11 2007-01-17 Glaxo Group Ltd Novel fluorescent kinase ligands and methods employing the same
UA99270C2 (en) 2006-12-12 2012-08-10 Лексикон Фармасьютикалз, Инк. 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
FR2910298A1 (fr) 2006-12-20 2008-06-27 Oreal Composition tinctoriale contenant une silicone reactive, un colorant fluorescent ou azurant optique, procede de coloration utilisant la composition
GB0625659D0 (en) 2006-12-21 2007-01-31 Cancer Rec Tech Ltd Therapeutic compounds and their use
TW200840566A (en) 2006-12-22 2008-10-16 Esteve Labor Dr Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments
EP1938686A1 (fr) 2006-12-29 2008-07-02 Bayer CropScience AG Acides de 1-(3-pyridinyl)pyrazol-4-yl acétique substitués, procédé pour leur préparation et leur utilisation comme herbicide et comme agent régulateur de la croissance des plantes
FR2911876B1 (fr) 2007-01-29 2009-03-06 Rhodia Recherches & Tech Nouveaux complexes organometalliques mixtes a base de carbenes a motif alkyllaminocyclique.
EP2121613A2 (fr) 2007-01-31 2009-11-25 Vertex Pharmaceuticals, Inc. Inhibiteurs de kinase
US20080269241A1 (en) 2007-02-15 2008-10-30 Darin Allen Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
EP1975159A1 (fr) 2007-03-27 2008-10-01 Bayer Schering Pharma Aktiengesellschaft 2,3,4,9-Tetrahydro-1H-carbazoles
EP1974729A1 (fr) 2007-03-28 2008-10-01 Santhera Pharmaceuticals (Schweiz) AG Dérivés d'imidazopyridine substitués en tant qu'antagonistes du récepteur de la mélanocortine- 4
AU2008236679B2 (en) 2007-04-03 2013-11-28 Fmc Corporation Substituted benzene fungicides
US8039505B2 (en) 2007-04-11 2011-10-18 University Of Utah Research Foundation Compounds for modulating T-cells
US7482492B2 (en) 2007-04-12 2009-01-27 Xerox Corporation Cost effective method for synthesis of triarylamine compounds
US20100256147A1 (en) 2007-04-13 2010-10-07 Hangauer Jr David G Biaryl acetamide derivatives as modulators of the kinase cascade for the treatment of hearing loss, osteoporosis and cell proliferation disorders
ES2366743T3 (es) 2007-04-27 2011-10-25 Agfa Graphics N.V. Precursor de placa de impresión litográfica.
EP2146702A2 (fr) 2007-05-03 2010-01-27 NorthEastern University Procédés de traitement d'infections fongiques
US8263585B2 (en) 2007-05-04 2012-09-11 Novartis Ag Organic compounds
US8222634B2 (en) 2007-05-17 2012-07-17 Lg Chem, Ltd. Anthracene derivatives and organic electronic device using the same
PE20090717A1 (es) * 2007-05-18 2009-07-18 Smithkline Beecham Corp Derivados de quinolina como inhibidores de la pi3 quinasa
EP1997493A1 (fr) 2007-05-28 2008-12-03 Laboratorios del Dr. Esteve S.A. Combinaison de ligand de récepteur de 5-HT7 et ligand de récepteur d'opiacés
TW200846319A (en) 2007-05-28 2008-12-01 China Petrochemical Dev Corp Method for preparing carbonate diester
WO2008150899A1 (fr) 2007-05-29 2008-12-11 Emory University Thérapies combinées pour le traitement du cancer et des maladies inflammatoires
TW200913776A (en) 2007-05-30 2009-03-16 Cheil Ind Inc Organic photoelectric device and material used therein
JP2009007342A (ja) 2007-06-01 2009-01-15 Mitsubishi Tanabe Pharma Corp 医薬組成物
WO2008151211A1 (fr) 2007-06-05 2008-12-11 Sanofi-Aventis Acides benzoylamino-indan-2-carboxyliques substitués et composés apparentés
JP5104060B2 (ja) 2007-06-25 2012-12-19 コニカミノルタホールディングス株式会社 有機エレクトロルミネッセンス素子材料、有機エレクトロルミネッセンス素子、表示装置及び照明装置
US8093291B2 (en) 2007-06-26 2012-01-10 Lexicon Pharmaceuticals, Inc. Methods of using and compositions comprising tryptophan hydroxylase inhibitors
GB0713259D0 (en) 2007-07-09 2007-08-15 Astrazeneca Ab Pyrazine derivatives 954
BRPI0814441A2 (pt) 2007-07-19 2015-07-14 Schering Corp Compostos de amida heterocíclica como inibidores de proteína cinase
MX2010001020A (es) 2007-07-26 2010-03-01 Novartis Ag Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas.
TWI388566B (zh) 2007-08-29 2013-03-11 Nat Univ Tsing Hua 含有碳烯配位基之過渡金屬錯合物及其在有機電激發光元件之應用
WO2009039181A2 (fr) 2007-09-17 2009-03-26 State Of Oregon Acting By & Through The State Board Of Higher Education On Behalf Of Or. State Univ. Organocatalyseurs à base de sulfonamide et procédé pour leur utilisation
WO2009051705A1 (fr) 2007-10-18 2009-04-23 Merck & Co., Inc. 1,2,4-oxadiazoles substitués et leurs analogues comme modulateurs des récepteurs cb2, utiles dans le traitement de la douleur et de maladies respiratoires et non respiratoires
FR2922550B1 (fr) 2007-10-19 2009-11-27 Sanofi Aventis Nouveaux derives de 6-aryl/heteroalkyloxy benzothiazole et benzimidazole, application comme medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de cmet
JP2011500806A (ja) 2007-10-25 2011-01-06 メルク・シャープ・エンド・ドーム・コーポレイション 治療用化合物
KR100957620B1 (ko) 2007-11-01 2010-05-13 제일모직주식회사 유기광전소자용 재료, 및 이를 이용한 유기광전소자
US7960547B2 (en) 2007-12-03 2011-06-14 Chien-Hong Cheng Transition metal complexes with carbene ligands and their application
CN101450939B (zh) 2007-12-05 2013-06-19 沈阳药科大学 新型苯并咪唑类化合物
WO2009073246A1 (fr) 2007-12-06 2009-06-11 Universal Display Corporation Procédé de synthèse de complexes d'iridium (iii) portant des ligands stériquement exigeants
EP2231636B1 (fr) 2007-12-07 2011-09-14 Novartis AG Dérivés de pyrazole et leur utilisation comme inhibiteurs de kinases dépendantes des cyclines
JP2009185020A (ja) 2008-01-11 2009-08-20 Ishihara Sangyo Kaisha Ltd ピリジルアミジン誘導体又はその塩、並びにそれらを有効成分として含有する農園芸用殺菌剤
GB0801199D0 (en) 2008-01-23 2008-02-27 Acal Energy Ltd Fuel cells
JP2011510033A (ja) 2008-01-25 2011-03-31 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト 化合物
UA106037C2 (uk) 2008-02-04 2014-07-25 Мерк'Юрі Терап'Ютікс, Інк. Модулятори ampk (амф-активованої протеїнкінази)
JP2011512357A (ja) 2008-02-15 2011-04-21 メルク・シャープ・エンド・ドーム・コーポレイション 縮合ピリドンｍ１受容体ポジティブアロステリックモジュレーター
WO2009105717A1 (fr) 2008-02-22 2009-08-27 Irm Llc Composés et compositions comme modulateurs d'activité de gpr119
GB0804067D0 (en) 2008-03-04 2008-04-09 Syngenta Participations Ag Chemical compounds
CA2718241A1 (fr) 2008-03-11 2009-09-17 Neurosearch A/S Nouveaux derives de triaryle utiles en tant que modulateurs de recepteurs d'acetylcholine nicotiniques
GB0804701D0 (en) 2008-03-13 2008-04-16 Amura Therapeutics Ltd Compounds
GB0804702D0 (en) 2008-03-13 2008-04-16 Amura Therapeutics Ltd Compounds
AU2009223693A1 (en) 2008-03-14 2009-09-17 Exelixis, Inc. Azabicyclo [3.2.1] octyl derivatives as 11 beta-HSD1 modulators
US8268834B2 (en) 2008-03-19 2012-09-18 Novartis Ag Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
FR2928922B1 (fr) 2008-03-21 2010-04-23 Sanofi Aventis Derives de 2-aryl-6-phenyl-imidazo°1,2-a!pyridines polysubstitues, leur preparation et leur application en therapeutique
WO2009120872A2 (fr) 2008-03-26 2009-10-01 Ada Technologies, Inc. Batteries de haute performance avec nanomatériaux de carbone et liquides ioniques
WO2009123241A1 (fr) 2008-03-31 2009-10-08 株式会社レナサイエンス Inhibiteur de l'inhibiteur de l'activateur du plasminogène-1
AU2009243756B2 (en) 2008-05-05 2013-06-27 Sanofi-Aventis Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
GB2472554B (en) 2008-05-05 2012-12-05 Ada Technologies Inc High performance carbon nanocomposites for ultracapacitors
FR2930939B1 (fr) 2008-05-09 2010-07-30 Sanofi Aventis Derives de pyrrole, leur preparation et leur application en therapeutique
WO2009144961A1 (fr) 2008-05-29 2009-12-03 興和株式会社 Composé de carbinol substitué ayant un lieur cyclique
CN101591332B (zh) 2008-05-30 2014-04-16 莱西肯医药有限公司 基于4-苯基-6-(2,2,2-三氟-1-苯基乙氧基)嘧啶的化合物及其应用方法
WO2009147190A1 (fr) 2008-06-05 2009-12-10 Glaxo Group Limited Nouveaux composés
CA2726610C (fr) 2008-06-05 2015-05-05 Asahi Kasei Pharma Corporation Composes de sulfonamide et leur utilisation
CN102131798A (zh) 2008-06-25 2011-07-20 英维沃医药有限公司 用作磷酸二酯酶10抑制剂的二取代的苯基化合物
KR101015858B1 (ko) 2008-06-26 2011-02-23 제일모직주식회사 유기 화합물, 및 이를 포함하는 유기 광전 소자
TW201002202A (en) 2008-06-27 2010-01-16 Du Pont Fungicidal pyridines
CN101619056B (zh) 2008-07-02 2013-07-17 石药集团中奇制药技术（石家庄）有限公司 苯并噻吩烷醇哌嗪衍生物及其作为抗抑郁症药物的应用
TWI436973B (zh) 2008-08-07 2014-05-11 China Petrochemical Dev Corp 碳氫化合物之液相氧化方法
US20100041642A1 (en) 2008-08-15 2010-02-18 Locus Pharmaceuticals, Inc. Urea inhibitors of map kinases
PT2344474E (pt) 2008-09-02 2015-12-28 Novartis Ag Derivados de picolinamida como inibidores de cinase
WO2010027583A1 (fr) 2008-09-03 2010-03-11 Universal Display Corporation Matières phosphorescentes
UA104147C2 (uk) 2008-09-10 2014-01-10 Новартис Аг Похідна піролідиндикарбонової кислоти та її застосування у лікуванні проліферативних захворювань
US20110294853A1 (en) 2008-09-12 2011-12-01 Benjamin Pelcman Bis Aromatic Compounds for Use in the Treatment of Inflammation
US20110237578A1 (en) 2008-09-18 2011-09-29 Zhi-Liang Wei Amide compounds, compositions and uses thereof
EP2168965A1 (fr) 2008-09-25 2010-03-31 Santhera Pharmaceuticals (Schweiz) AG Dérivés d'imidazopyridine, d'imidazopyrazine et d'imidazopyridazine substitués en tant qu'antagonistes de récepteur de la mélanocortine-4
US20120022070A1 (en) 2008-10-06 2012-01-26 Emory University Heat Shock Protein 90 Inhibitors, Methods Of Preparing Same, And Methods For Their Use
WO2010042799A2 (fr) 2008-10-09 2010-04-15 Howard Hughes Medical Institute Canaux ioniques chimériques inédits activés par la fixation d'un ligand et leurs procédés d'utilisation
US8435911B2 (en) 2008-10-16 2013-05-07 Basell Polyolefine Gmbh Hybrid catalyst composition for polymerization of olefins
FR2937262B1 (fr) 2008-10-17 2010-11-05 Inst Francais Du Petrole Procede de preparation d'une composition catalytique pour la dimerisation, la co-dimerisation et l'oligomerisation des olefines.
JP2012506381A (ja) 2008-10-21 2012-03-15 バーテックス ファーマシューティカルズ インコーポレイテッド ｃ−ＭＥＴタンパク質キナーゼ阻害剤
CN102203069A (zh) 2008-10-24 2011-09-28 莱西肯医药有限公司 被取代的苯基丙氨酸的制备方法
KR101712576B1 (ko) 2008-11-10 2017-03-06 버텍스 파마슈티칼스 인코포레이티드 Ａｔｒ 키나제의 억제제로서 유용한 화합물
WO2010056992A1 (fr) 2008-11-13 2010-05-20 The Trustees Of Columbia University In The City Of New York Procédés de prévention et de traitement de maladies de faible masse osseuse
WO2010061903A1 (fr) * 2008-11-27 2010-06-03 塩野義製薬株式会社 Dérivé de pyrimidine et dérivé de pyridine présentant tous deux une activité inhibitrice de pi3k
WO2010065333A1 (fr) 2008-12-01 2010-06-10 Lexicon Pharmaceuticals, Inc. Composés à base de 4-phényl-6-(2,2,2-trifluoro-1-phényléthoxy)pyrimidine pour le traitement de l’ostéoporose
JP2010143829A (ja) 2008-12-16 2010-07-01 Dainippon Sumitomo Pharma Co Ltd 新規なイミダゾキノリン誘導体
KR20110099740A (ko) 2008-12-18 2011-09-08 이 아이 듀폰 디 네모아 앤드 캄파니 글루타로니트릴로부터 다이아미노피리딘의 합성을 위한 연속 액체상 방법
DE102009055828A1 (de) 2008-12-19 2010-07-01 Merck Patent Gmbh Verfahren zur Herstellung metallbeschichteter Partikel
PL3354650T3 (pl) 2008-12-19 2022-06-13 Vertex Pharmaceuticals Incorporated Związki przydatne jako inhibitory kinazy atr
TW201024259A (en) 2008-12-24 2010-07-01 China Petrochemical Dev Corp Method for preparing organic carboxylic acid ester
CN101781200B (zh) 2009-01-20 2013-04-03 中国石油化学工业开发股份有限公司 有机羧酸酯的制造方法
EP2393787B1 (fr) 2009-02-09 2018-01-24 Georgetown University Inhibiteurs de la cadhérine-11 et méthodes d'utilisation associées
KR101699991B1 (ko) 2009-02-11 2017-01-26 메르크 파텐트 게엠베하 신규의 아미노 아자헤테로시클릭 카르복사미드
WO2010100475A1 (fr) 2009-03-02 2010-09-10 Astrazeneca Ab Dérivés de l'acide hydroxamique en tant qu'agents contre des bactéries à gram négatif
CN101513584B (zh) 2009-03-04 2011-11-09 中国科学院过程工程研究所 一种基于碱性离子液体催化剂的氧化脱硫方法
WO2010111573A1 (fr) 2009-03-27 2010-09-30 Abbott Laboratories Composés utilisés comme ligands des récepteurs cannabinoïdes
NZ596185A (en) * 2009-04-16 2013-01-25 Ct Nac Investigaciones Oncologicas Cnio Imidazopyrazines for use as kinase inhibitors
UY32582A (es) 2009-04-28 2010-11-30 Amgen Inc Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamífero
JP2012162460A (ja) 2009-05-27 2012-08-30 Nippon Soda Co Ltd 含窒素ヘテロアリール誘導体および農園芸用殺菌剤
WO2010138901A1 (fr) 2009-05-29 2010-12-02 Biogen Idec Ma Inc Composés contenant de l'acide carboxylique, leurs dérivés et procédés d'utilisation associés
WO2010148351A1 (fr) 2009-06-18 2010-12-23 Cylene Pharmaceuticals, Inc. Rhodanines et hétérocycles associés en tant qu'inhibiteurs de kinase
EP2445879A1 (fr) 2009-06-25 2012-05-02 Institut Univ. de Ciència i Tecnologia, S.A. N-(2-oxo-1-phénylpipéridin-3-yl)sulfonamides pour l'identification d'une activité biologique et pharmacologique
ES2354550B1 (es) 2009-06-26 2011-11-15 Institut Univ. De Ciència I Tecnologia, S.A. Biblioteca de n-(1-fenil-2-oxo-3-piperidil)sulfonamidas para el descubrimiento de fármacos.
ES2354551B1 (es) 2009-07-01 2011-11-15 Institut Univ. De Ciencia I Tecnologia S.A. Bibliotecas de n-(1-fenil-2-oxo-3-piperidil)sulfonamidas para la identificación de actividad biológica y farmacológica.
UA102916C2 (uk) 2009-07-02 2013-08-27 Кемфарм, Інк. Композиція на основі кон'югату гідрокодону з бензойною кислотою, похідними бензойної кислоти або гетероарилкарбоновою кислотою, проліки, спосіб лікування від зловживань
JP2014501489A (ja) 2009-07-06 2014-01-23 アルナイラム ファーマシューティカルズ， インコーポレイテッド 細胞ベースのバイオプロセシング
JP2014501097A (ja) 2009-07-06 2014-01-20 アルナイラム ファーマシューティカルズ， インコーポレイテッド 生物由来物質の産生を高めるための組成物及び方法
WO2011005842A1 (fr) 2009-07-09 2011-01-13 Gilead Sciences, Inc. Composés anti-vrs
AR077468A1 (es) 2009-07-09 2011-08-31 Array Biopharma Inc Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
JP4590020B1 (ja) 2009-07-31 2010-12-01 富士フイルム株式会社 電荷輸送材料及び有機電界発光素子
JP4599469B1 (ja) 2009-08-31 2010-12-15 富士フイルム株式会社 有機電界発光素子用材料及び有機電界発光素子
FR2949465B1 (fr) 2009-09-01 2011-08-12 Pf Medicament Derives chromones, leur procede de preparation et leurs applications therapeutiques
WO2011028638A1 (fr) 2009-09-04 2011-03-10 Schering Corporation Modulateurs de points de contrôle du cycle cellulaire et leur utilisation en combinaison avec des inhibiteurs de kinase de point de contrôle
WO2011032034A2 (fr) 2009-09-10 2011-03-17 University Of Idaho Nucléotides et oligonucléotides à conformation restreinte à fonctionnalité nucléobase pour cibler des acides nucléiques
JP2013504604A (ja) 2009-09-18 2013-02-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ウイルスポリメラーゼ阻害剤としてのキナゾリノン誘導体
WO2011036461A1 (fr) 2009-09-24 2011-03-31 Centro Nacional De Investigaciones Oncόlogicas (Cnio) Imidazo [3, 2 - d] pyrazines fusionnées utilisées en tant qu'inhibiteurs de la kinase pi3
DE102009043260A1 (de) 2009-09-28 2011-04-28 Merck Patent Gmbh Pyridinyl-imidazolonderivate
EP2486005B1 (fr) 2009-10-06 2014-06-18 Bristol-Myers Squibb Company Modulateurs du gpr40 à base de pyrrolidine
EP2490530A4 (fr) 2009-10-22 2014-01-22 Univ Washington Composés et méthodes pour le traitement d'infections bactériennes
WO2011049150A1 (fr) 2009-10-22 2011-04-28 Sumitomo Chemical Company, Limited Composé de pyrone et son utilisation pour lutter contre les organismes nuisibles
CN101712809A (zh) 2009-10-30 2010-05-26 上海拓引数码技术有限公司 一种有机染料、其制备方法及含该有机染料的可录式光学信息记录介质
US8759377B2 (en) 2009-11-23 2014-06-24 Vanderbilt University Substituted dioxopiperidines and dioxopyrrolidines as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
CA3044884A1 (fr) 2009-12-07 2011-06-16 Arbutus Biopharma Corporation Compositions utilisees pour l'administration d'acides nucleiques
WO2011072064A1 (fr) 2009-12-08 2011-06-16 Array Biopharma Inc. Spiro[chromane-4,4'-imidazol]ones en tant qu'inhibiteurs de bêta-sécrétase
US20120245155A1 (en) 2009-12-11 2012-09-27 Shionogi & Co., Ltd. Fused heterocyclic compound having amino group
WO2011081945A2 (fr) 2009-12-14 2011-07-07 Cornell University Activation et activateurs de sirt6
AU2010333338A1 (en) 2009-12-14 2012-08-02 Merck Patent Gmbh Sphingosine kinase inhibitors
WO2011081937A1 (fr) 2009-12-15 2011-07-07 Gilead Sciences, Inc. Composés de type corticostéroïde-bêta-agoniste-antagoniste muscarinique pour applications thérapeutiques
WO2011083304A1 (fr) 2010-01-05 2011-07-14 Shire Llc Promédicaments d'opioïdes et leurs utilisations
US20130109758A1 (en) 2010-01-06 2013-05-02 The University Of British Columbia Bisphenol derivative therapeutics and methods for their use
HRP20151143T1 (hr) 2010-01-18 2015-12-04 Mmv Medicines For Malaria Venture Novi antimalarijski agensi
ES2545865T3 (es) 2010-01-27 2015-09-16 Boehringer Ingelheim International Gmbh Compuestos de pirazol como antagonistas de CRTH2
EP2531500B1 (fr) 2010-02-05 2018-01-24 Merck Patent GmbH Dérivés d'hétaryl-[1,8]naphtyridine
CA2793223A1 (fr) 2010-03-16 2011-09-22 Aventis Pharmaceuticals Inc. Pyrimidines substituees en tant qu'antagonistes du recepteur d2 de prostaglandines
CA2794801C (fr) 2010-04-07 2019-01-15 F. Hoffmann-La Roche Ag Composes pyrazol-4-yl-heterocyclyle-carboxamide et leurs procedes d'utilisation
CN107441097A (zh) 2010-04-16 2017-12-08 阿西纳斯公司 用于预防和治疗癌症的组合物以及方法
JP2013526538A (ja) 2010-05-12 2013-06-24 バーテックス ファーマシューティカルズ インコーポレイテッド Ａｔｒキナーゼ阻害剤として有用な化合物
FR2959944B1 (fr) 2010-05-12 2012-06-08 Inst Francais Du Petrole Solution absorbante contenant un inhibiteur de degradation derive de la pyridine et procede d'absorption de composes acides contenus dans un effluent gazeux.
US9096584B2 (en) 2010-05-12 2015-08-04 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
CN103221404B (zh) 2010-05-13 2015-12-16 安姆根有限公司 可用作pde10抑制剂的不饱和氮杂环化合物
TWI428343B (zh) 2010-05-14 2014-03-01 Nat Univ Tsing Hua 無硫氰酸根配基的光敏錯合物及敏化染料太陽能電池
WO2011147038A1 (fr) 2010-05-28 2011-12-01 The Royal Institution For The Advancement Of Learning/Mcgill University Acide hétérocyclyle-pyridinyle bisphosphonique, sel pharmaceutiquement acceptable de celui-ci, composition en contenant et son procédé d'utilisation
US8889768B2 (en) 2010-06-11 2014-11-18 Basf Se Laser-transparent PBT with organic additives
WO2011161612A1 (fr) 2010-06-22 2011-12-29 Basf Se Procédé de préparation de 4-hydroxypyridines
UY33469A (es) 2010-06-29 2012-01-31 Irm Llc Y Novartis Ag Composiciones y metodos para modular la via de señalizacion de wnt
SG186871A1 (en) 2010-07-05 2013-02-28 Merck Patent Gmbh Bipyridyl derivatives useful for the treatment of kinase - induced diseases
CA2804351A1 (fr) 2010-07-12 2012-01-19 Pfizer Limited Composes chimiques
EP2593431B1 (fr) 2010-07-12 2014-11-19 Pfizer Limited N-sulfonylbenzamides comme inhibiteurs des canaux sodiques voltage-dépendant
ES2550939T3 (es) 2010-07-16 2015-11-13 Nivalis Therapeutics, Inc. Nuevos compuestos de dihidropiridin-2-(1H)-ona como inhibidores de la S-nitrosoglutatión reductasa y antagonistas del receptor de la neurocinina-3
JP5587701B2 (ja) 2010-08-06 2014-09-10 日本エンバイロケミカルズ株式会社 実験用水循環／収容装置用微生物防除剤、および実験用水循環／収容装置の微生物防除方法
EP2613781B1 (fr) 2010-09-08 2016-08-24 GlaxoSmithKline Intellectual Property Development Limited Dérivés indazole à utiliser dans le traitement d'une infection par le virus de la grippe
EP2617715A4 (fr) 2010-09-17 2014-02-26 Taisho Pharmaceutical Co Ltd Inhibiteur de transporteur de glycine
ES2379919B1 (es) 2010-10-06 2013-03-19 Consejo Superior De Investigaciones Científicas (Csic) SÍNTESIS DE PIRIDONAS BICÍCLICAS QUE CONTIENEN EL SISTEMA HETEROCÍCLICO DE IMIDAZOL(1,2-a)PIRIDINA, A PARTIR DE 2-AMINO-6-(PROP-2-IN-1-IL AMINO) PIRIDINAS.
JP2013544827A (ja) 2010-11-24 2013-12-19 エクセリクシス， インク． ＰＩ３Ｋ／ｍＴＯＲの阻害剤としてのベンゾオキサゼピン類ならびにそれらの使用法および製造法
GB201020161D0 (en) 2010-11-26 2011-01-12 Almac Discovery Ltd Pharmaceutical compounds
IT1402842B1 (it) 2010-11-30 2013-09-27 Annunziato 7-nitro-5-fenil-1(pirrolidin-1-ilmetil)-1h-benzo[e][1,4] diazepin-2(3h)-one ed altri composti derivati delle benzodiazepine.
KR101728898B1 (ko) 2010-12-07 2017-04-21 광주과학기술원 신규한 하이드라진 유도체 및 이의 용도
DE102010054892A1 (de) 2010-12-17 2012-06-21 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zur Herstellung eines Polyesters sowie Zusammensetzung und Formkörper umfassend einen derartigen Polyester
CN102125875B (zh) 2011-01-20 2012-09-05 郑州大学 二茂铁亚胺环钯-膦加合物在不对称联芳化合物合成中的应用
WO2012108879A1 (fr) 2011-02-11 2012-08-16 Universal Display Corporation Dispositif électroluminescent organique et matériaux pour utilisation dans celui-ci
IT1404379B1 (it) 2011-02-11 2013-11-22 Lembo Eterocicli ad attivita' antiipertensiva
JP5964328B2 (ja) 2011-02-11 2016-08-03 ユニバーサル ディスプレイ コーポレイション 有機発光素子及び該有機発光素子に使用されるための材料
WO2012112958A2 (fr) 2011-02-19 2012-08-23 The Broad Institute, Inc Dosages à grand rendement destinés à détecter la leucémie dans la niche stromale
US20140171525A1 (en) 2011-02-21 2014-06-19 Honeywell International Inc. Polyurethane foam premixes containing halogenated olefin blowing agents and foams made from same
US11179500B2 (en) 2011-02-24 2021-11-23 Emory University JAB1 inhibitory compositions for ossification and methods related thereto
JP5970003B2 (ja) 2011-03-04 2016-08-17 ローカス ファーマシューティカルズ インコーポレイテッド アミノピラジン化合物
US9108984B2 (en) * 2011-03-14 2015-08-18 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
CN103097367B (zh) 2011-04-02 2014-12-03 中国人民解放军军事医学科学院毒物药物研究所 苯丙酸化合物、其制备方法及其医药用途
CA2832100A1 (fr) 2011-04-05 2012-10-11 Vertex Pharmaceuticals Incorporated Composes aminopyrazines utiles en tant qu'inhibiteurs de la kinase atr
PH12013501829A1 (en) 2011-04-12 2015-10-23 Chong Kun Dang Pharmaceutical Corp Cycloalkenyl aryl derivatives for cetp inhibitor
EP2704701B1 (fr) 2011-05-03 2018-01-03 PRCL Research Inc. Composés pour une inflammation et des utilisations apparentées au système immunitaire
US20120289481A1 (en) 2011-05-13 2012-11-15 O'neil Jennifer Compositions and methods for treating cancer
EP2524918A1 (fr) 2011-05-19 2012-11-21 Centro Nacional de Investigaciones Oncológicas (CNIO) Imidazopyrazines en tant qu'inhibiteurs de kinase
TW201302763A (zh) 2011-05-24 2013-01-16 必治妥美雅史谷比公司 用於減少β－類澱粉產生之化合物
AU2012265219B2 (en) 2011-05-31 2017-02-16 Merck Patent Gmbh Compounds containing hydrido-tricyano-borate anions
AR086653A1 (es) 2011-06-03 2014-01-15 Bristol Myers Squibb Co COMPUESTOS PARA LA REDUCCION DE PRODUCCION DE b-AMILOIDE
CN102260218B (zh) 2011-06-07 2013-05-08 北京理工大学 一种胺基吡嗪香料的合成方法
ITMI20110208U1 (it) 2011-06-17 2012-12-18 Masterlab S R L Unipersonale Dispositivo per il collegamento a un profilato per telai di serramenti con canale aperto di una piastra di copertura di detto canale e kit di copertura di un canale aperto di un profilato per telai di serramenti
WO2012178123A1 (fr) 2011-06-22 2012-12-27 Vertex Pharmaceuticals Incorporated Composés utiles comme inhibiteurs de la kinase atr
WO2012177639A2 (fr) 2011-06-22 2012-12-27 Alnylam Pharmaceuticals, Inc. Biotraitement et bioproduction à l'aide de lignées de cellules aviaires
WO2012178125A1 (fr) 2011-06-22 2012-12-27 Vertex Pharmaceuticals Incorporated Composés inhibiteurs de la kinase atr
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
CN102850328B (zh) 2011-07-01 2014-12-24 苏州东南药业股份有限公司 吡啶类化合物、其制备方法、包含该化合物的药物组合物及其用途
KR101502500B1 (ko) 2011-07-01 2015-03-16 주식회사 엘지화학 비수 전해액 및 이를 이용한 리튬 이차전지
EP2543673A1 (fr) 2011-07-08 2013-01-09 cynora GmbH Complexes de cuivre(I) pour dispositifs optoélectroniques
MX2014001457A (es) 2011-08-05 2014-08-21 Abbvie Deutschland Derivados de aminocromano, de aminotiocromano y de amino-1,2,3,4-tetrahidroquinolina composiciones farmaceuticas que los contienen, y su uso en terapia.
US9394293B2 (en) 2011-08-10 2016-07-19 Purdue Pharma L.P. TRPV1 antagonists including dihydroxy substituent and uses thereof
CN103842342A (zh) 2011-08-12 2014-06-04 巴斯夫欧洲公司 邻氨基苯甲酰胺化合物及其作为农药的用途
BR112014003221A2 (pt) 2011-08-12 2017-04-18 Basf Se composto da fórmula geral (i), método para preparação de um comporto da fórmula (i), composição agrícola ou veterinária, métodos para combater ou controlar pragas invertebradas, para a proteção de plantas em crecimento contra o ataque ou infestação por pragas invertebradas, para a proteção de sementes contra insetos terrestres e das raízes e galhos de mudas contra insetos terrestres e foliares, semente, uso de um composto e método para tratamento de um animal infestado ou infectado por parasitas ou para evitar que animais fiquem infestados ou infectados por parasitas ou para proteção de um animal contra infestação ou infecção por parasitas
AU2012296639B2 (en) 2011-08-15 2016-06-09 University Of Utah Research Foundation Substituted (E)-N'-(1-phenylethylidene) benzohydrazide analogs as histone demethylase inhibitors
BR112014003595A2 (pt) 2011-08-18 2017-03-01 Basf Se compostos, método de preparação de um composto, composição agrícola, método de combate ou controle de pestes invertebradas, métodos de proteção do crescimento de plantas e de proteção de sementes, semente, uso de um composto e método de tratamento de animal infestado
CL2014000498A1 (es) 2011-08-29 2014-12-19 Infinity Pharmaceuticals Inc Compuestos heterociclicos, inhibidores selectivos de isoformas de pi3k de clase i; composicion farmaceutica que los comprende; y metodo para tratar un trastorno selccionado de cancer, una enfermedad antiinflamaoria o una enfermedad autoinmune.
MX389479B (es) 2011-09-02 2025-03-20 Incyte Holdings Corp Heterociclilaminas como inhibidores de fosfoinositida 3-cinasas (pi3k)
US9518217B2 (en) 2011-09-06 2016-12-13 E Ink Holdings Inc. Transition metal carbene complexes and the electroluminescent application thereof
US9233996B2 (en) 2011-09-13 2016-01-12 California Institute Of Technology Multi-metallic organometallic complexes, and related polymers, compositions, methods and systems
WO2013042137A1 (fr) 2011-09-19 2013-03-28 Aurigene Discovery Technologies Limited Hétérocycles bicycliques convenant comme inhibiteurs de l'irak4
CN103814037A (zh) 2011-09-20 2014-05-21 道康宁公司 含锰硅氢加成催化剂及含有该催化剂的组合物
US20140182483A1 (en) 2011-09-20 2014-07-03 Dow Corning Corporation Titanium Containing Hydrosilylation Catalysts And Compositions Containing The Catalysts
WO2013043767A2 (fr) 2011-09-20 2013-03-28 Dow Corning Corporation Catalyseurs d'hydrosilylation contenant du rhénium et compositions contenant les catalyseurs
US20140225027A1 (en) 2011-09-20 2014-08-14 Dow Corning Corporation Silver Containing Hydrosilylation Catalysts And Compositions Containing The Catalysts
WO2013043799A1 (fr) 2011-09-20 2013-03-28 Dow Corning Corporation Catalyseurs d'hydrosilylation contenant du zirconium et compositions contenant les catalyseurs
US20140228570A1 (en) 2011-09-20 2014-08-14 Dow Corning Corporation Hydrosilylation Catalysts Made With Terdentate Nitrogen Ligands And Compositions Containing The Catalysts
WO2013043765A2 (fr) 2011-09-20 2013-03-28 Dow Corning Corporation Catalyseurs d'hydrosilylation contenant de l'hafnium et compositions contenant les catalyseurs
JP2015501287A (ja) 2011-09-20 2015-01-15 ダウ コーニング コーポレーションＤｏｗ Ｃｏｒｎｉｎｇ Ｃｏｒｐｏｒａｔｉｏｎ バナジウム含有ヒドロシリル化触媒及びこの触媒を含有する組成物
CN104024267A (zh) 2011-09-20 2014-09-03 道康宁公司 含铁硅氢加成催化剂及含有该催化剂的组合物
RU2018147217A (ru) 2011-09-30 2019-01-18 Вертекс Фармасьютикалз Инкорпорейтед Способы получения соединений, которые можно использовать в качестве ингибиторов киназы atr
WO2013052391A1 (fr) 2011-10-05 2013-04-11 Merck Sharp & Dohme Corp. Inhibiteurs de tyrosine kinase de la rate (syk) contenant un phényl carboxamide
US9123897B2 (en) 2011-10-14 2015-09-01 Hodogaya Chemical Co., Ltd. Benzotriazole derivatives and organic electroluminescent devices using the derivatives
CN108409662B (zh) 2011-10-17 2021-10-26 约翰斯霍普金斯大学 作为hno供体的经羟胺取代的米氏酸、巴比妥酸和吡唑啉酮衍生物
IN2014DN03009A (fr) 2011-10-26 2015-05-08 Kempharm Inc
US9586964B2 (en) 2011-10-28 2017-03-07 Vanderbilt University Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M1
CN103087050A (zh) 2011-10-28 2013-05-08 山东轩竹医药科技有限公司 芳基激酶抑制剂
JPWO2013069242A1 (ja) 2011-11-07 2015-04-02 出光興産株式会社 有機エレクトロルミネッセンス素子用材料及びそれを用いた有機エレクトロルミネッセンス素子
EP2776429A1 (fr) 2011-11-09 2014-09-17 Vertex Pharmaceuticals Incorporated Composés utiles comme inhibiteurs de kinase atr
WO2013071090A1 (fr) 2011-11-09 2013-05-16 Vertex Pharmaceuticals Incorporated Composés utiles en tant qu'inhibiteurs de la kinase atr
EP2776421A1 (fr) 2011-11-09 2014-09-17 Vertex Pharmaceuticals Incorporated Composés utiles comme inhibiteurs de kinase atr
US8841450B2 (en) 2011-11-09 2014-09-23 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
WO2013072758A1 (fr) 2011-11-15 2013-05-23 Purdue Pharma L.P. Pyrimidine diol amides comme bloqueurs des canaux sodiques
ES2565821T3 (es) 2011-11-21 2016-04-07 Basf Se Proceso para preparar compuestos 1H-pirazol-5-carboxilato N-sustituidos y derivados de los mismos
JP2013129653A (ja) 2011-11-22 2013-07-04 Nissan Chem Ind Ltd トリアゾ−ル誘導体および有害生物防除剤
JP2013129651A (ja) 2011-11-22 2013-07-04 Nissan Chem Ind Ltd チアゾール誘導体および有害生物防除剤
ES2593533T3 (es) 2011-12-15 2016-12-09 Pfizer Limited Derivados de sulfonamida
ES2661510T3 (es) 2011-12-15 2018-04-02 Novartis Ag Uso de inhibidores de la actividad o función de PI3K
US8969325B2 (en) 2011-12-19 2015-03-03 Abbvie Inc. TRPV1 antagonists
CN103159738B (zh) 2011-12-19 2016-09-07 上海泓博智源医药股份有限公司 炔基桥连的杂芳香化合物及其应用
US8859584B2 (en) 2011-12-19 2014-10-14 Abbvie, Inc. TRPV1 antagonists
WO2013092936A2 (fr) 2011-12-20 2013-06-27 Galderma Research & Development Utilisation d'acide 5-aminolévulinique et d'esters, en combinaison avec un dérivé ou un analogue de la vitamine d en photochimiothérapie, et leurs utilisations dans le traitement de l'acné
US20130190356A1 (en) 2011-12-22 2013-07-25 Genentech, Inc. Benzyl sulfonamide derivatives as rorc modulators
JP2014015447A (ja) 2011-12-22 2014-01-30 Nissan Chem Ind Ltd ピラゾール誘導体および有害生物防除剤
US20150001516A1 (en) 2011-12-27 2015-01-01 Konica Minolta, Inc. Transparent electrode, electronic device, organic electroluminescence element, and method for manufacturing organic electroluminescence elements
CA2860553C (fr) 2012-01-04 2016-08-23 Pfizer Limited N-aminosulfonylbenzamides
IN2012DE00110A (fr) 2012-01-11 2015-05-08 Syngenta Ltd
SG11201404505PA (en) 2012-01-31 2014-10-30 Daiichi Sankyo Co Ltd Pyridone derivative
WO2013117649A1 (fr) 2012-02-10 2013-08-15 Galapagos Nv Dérivés d'imidazo [4, 5-c] pyridine utiles pour le traitement de maladies dégénératives et inflammatoires
US9138492B2 (en) 2012-02-23 2015-09-22 Canon Kabushiki Kaisha Particle containing hydrophobic dye having cyanine structure, and contrast agent containing the particle
EP2822944A1 (fr) 2012-03-05 2015-01-14 Amgen, Inc. Composés d'oxazolidinone et leurs dérivés
EP2830625A1 (fr) 2012-03-28 2015-02-04 Merck Sharp & Dohme Corporation Inhibiteurs du récepteur du facteur 1 de croissance analogue à l'insuline
FR2988722B1 (fr) 2012-04-03 2014-05-09 Sanofi Sa Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques
DE102012006896A1 (de) 2012-04-05 2013-10-10 Merck Patent Gmbh Silikate mit organischen Kationen
US8940742B2 (en) * 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
CN104245714B (zh) 2012-04-12 2017-09-26 港大科桥有限公司 供oled应用的铂(ii)络合物
WO2013162061A1 (fr) 2012-04-26 2013-10-31 第一三共株式会社 Composé de pyrimidine bicyclique
WO2013161929A1 (fr) 2012-04-26 2013-10-31 塩野義製薬株式会社 Dérivé de pyridinyl-morpholinone et composition médicamenteuse contenant celui-ci
KR101383239B1 (ko) 2012-04-30 2014-04-10 한국화학연구원 베타-세크리테아제 활성을 억제하는 4-(벤즈이미다졸-2-일아미노)피롤리딘 유도체 및 이를 유효성분으로 함유하는 약제학적 조성물
EP2844655A1 (fr) 2012-05-02 2015-03-11 Lupin Limited Composés substitués de pyridine en tant que modulateurs de crac
JP2014001205A (ja) 2012-05-22 2014-01-09 Nissan Chem Ind Ltd 動物の寄生虫防除剤
GB201209670D0 (en) 2012-05-31 2012-07-18 Convergence Pharmaceuticals Novel compounds
US20150150935A1 (en) 2012-06-05 2015-06-04 Cara Therapeutics, Inc. Peripheral kappa receptor agonists for reducing pain and inflammation
EP2676947A1 (fr) 2012-06-18 2013-12-25 LANXESS Deutschland GmbH Procédé d'isomérisation de plantes aromatiques substituées au moyen d'un bain de sels fondus
CN103524372B (zh) 2012-07-03 2015-06-10 南京圣和药业股份有限公司 一种组蛋白去乙酰化酶抑制剂
JP2014111559A (ja) 2012-07-04 2014-06-19 Nissan Chem Ind Ltd ピラゾール誘導体および有害生物防除剤
WO2014007395A1 (fr) 2012-07-06 2014-01-09 日産化学工業株式会社 Dérivé de pyrazole ou de thiazole, sel de celui-ci, et agent de lutte contre les ravageurs
JP2015003895A (ja) 2012-07-06 2015-01-08 日産化学工業株式会社 チアゾール誘導体および有害生物防除剤
WO2014011768A1 (fr) 2012-07-10 2014-01-16 Adispell, Inc. Traitement anxiolytique
CN104487429B (zh) 2012-07-27 2017-07-14 爱默蕾大学 杂环黄酮衍生物、组合物及与其相关的方法
JP2015524483A (ja) 2012-08-09 2015-08-24 ニューロポア セラピーズ，インコーポレイティド Ｐｉ３−キナーゼシグナリング経路の調節因子としてのアリール及びヘテロアリールで置換されたベンゼン誘導体
JP2014037382A (ja) 2012-08-17 2014-02-27 Nissan Chem Ind Ltd 殺虫、殺ダニ、殺線虫、殺軟体動物、殺菌又は殺バクテリア剤組成物及び病害虫の防除方法
WO2014033631A1 (fr) 2012-08-31 2014-03-06 Novartis Ag N- (3-pyridyl)-biarylamides en tant qu'inhibiteurs de kinase
JP6318156B2 (ja) 2012-09-06 2018-04-25 プレキシコン インコーポレーテッドＰｌｅｘｘｉｋｏｎ Ｉｎｃ． キナーゼをモジュレートするための化合物および方法、ならびにその指標
CN103664878A (zh) 2012-09-12 2014-03-26 山东亨利医药科技有限责任公司 杂芳环及其衍生物类酪氨酸激酶抑制剂
WO2014048939A1 (fr) 2012-09-26 2014-04-03 F. Hoffmann-La Roche Ag Composés d'éther cyclique-pyrazol-4-yl-hétérocyclyl-carboxamide et procédés d'utilisation
JP5994551B2 (ja) 2012-10-10 2016-09-21 コニカミノルタ株式会社 エレクトロルミネッセンスデバイス
JP6127436B2 (ja) 2012-10-10 2017-05-17 コニカミノルタ株式会社 白色エレクトロルミネッセンスデバイス及び白色エレクトロルミネッセンスデバイスの製造方法
TWI598325B (zh) 2012-10-12 2017-09-11 Ｈ 朗德貝克公司 苯甲醯胺類
JP6015765B2 (ja) 2012-10-22 2016-10-26 コニカミノルタ株式会社 透明電極、電子デバイスおよび有機エレクトロルミネッセンス素子
JP6231009B2 (ja) 2012-10-22 2017-11-15 コニカミノルタ株式会社 透明電極、電子デバイスおよび有機エレクトロルミネッセンス素子
WO2014065209A1 (fr) 2012-10-23 2014-05-01 日本曹達株式会社 Composé de pyridine ou son sel, agent de lutte antiparasitaire, insecticide ou acaricide et agent de lutte anti-ectoparasitaire
KR102000211B1 (ko) 2012-10-29 2019-09-30 삼성디스플레이 주식회사 유기금속 화합물 및 이를 포함한 유기 발광 소자
PE20150974A1 (es) 2012-11-14 2015-07-04 Teijin Pharma Ltd Derivados de piridina
WO2014079805A1 (fr) 2012-11-23 2014-05-30 Boehringer Ingelheim International Gmbh Composés de pyrazole pour traiter l'alopécie
CN104245693B (zh) 2012-12-14 2016-08-24 上海恒瑞医药有限公司 嘧啶类衍生物及其可药用盐、其制备方法及其在医药上的应用
EP2935256B1 (fr) 2012-12-19 2018-01-24 Bristol-Myers Squibb Company 4,6-diarylaminothiazines à titre d'inhibiteurs de bace1 et leur utilisation pour réduire la production des bêta-amyloïdes
EP2934518B1 (fr) 2012-12-19 2020-02-19 Merck Sharp & Dohme Corp. Inhibiteurs de la cetp spirocycliques
WO2014099834A1 (fr) 2012-12-20 2014-06-26 Merck Sharp & Dohme Corp. Composés de thiazolidinone thérapeutiques
KR20140083620A (ko) 2012-12-26 2014-07-04 제일모직주식회사 차광층용 감광성 수지 조성물 및 이를 이용한 차광층
JP5911419B2 (ja) 2012-12-27 2016-04-27 キヤノン株式会社 有機発光素子及び表示装置
CN103896946B (zh) 2012-12-28 2018-04-03 浙江导明医药科技有限公司 用于预防及治疗多种自身免疫疾病的新化合物
WO2013171729A2 (fr) 2013-01-08 2013-11-21 Glenmark Pharmaceuticals S.A. Composés d'aryl- et hétéroarylamide en tant que modulateur de rorγt
TW201443037A (zh) 2013-01-09 2014-11-16 Gilead Sciences Inc 治療用化合物
CN103694236B (zh) 2013-01-15 2017-05-31 苏州开拓药业股份有限公司 一种嘧啶骨架具有刺猬通路拮抗剂活性的抗肿瘤化合物
TWI662030B (zh) 2013-01-15 2019-06-11 英塞特控股公司 適用作ｐｉｍ激酶抑制劑之噻唑甲醯胺及吡啶甲醯胺化合物
AU2014211856C1 (en) 2013-02-02 2018-04-12 Centaurus Biopharma Co., Ltd. Substituted 2-aminopyridine protein kinase inhibitor
WO2014130582A2 (fr) 2013-02-19 2014-08-28 Senomyx, Inc. Composés utiles comme modulateurs de trpm8
EA027879B1 (ru) 2013-02-22 2017-09-29 Пфайзер Инк. ПРОИЗВОДНЫЕ ПИРРОЛО[2,3-d]ПИРИМИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ ЯНУС-РОДСТВЕННЫХ КИНАЗ (JAK)
CN103923085B (zh) 2013-02-25 2016-08-24 苏州云轩医药科技有限公司 具有刺猬通路拮抗剂活性的吡啶杂环化合物及其用途
TWI736135B (zh) 2013-03-01 2021-08-11 美商英塞特控股公司 吡唑并嘧啶衍生物治療PI3Kδ相關病症之用途
EP2774919A1 (fr) 2013-03-06 2014-09-10 Pharmeste S.R.L. In Liquidazione Nouveaux antagonistes des récepteurs TRPA1 de sulfonamide
JP6362367B2 (ja) 2013-03-12 2018-07-25 花王株式会社 酸化性組成物
JP2014198841A (ja) 2013-03-12 2014-10-23 花王株式会社 酸化性組成物
US8993771B2 (en) 2013-03-12 2015-03-31 Novira Therapeutics, Inc. Hepatitis B antiviral agents
JP6279358B2 (ja) 2013-03-12 2018-02-14 花王株式会社 酸化性組成物
AU2014249233A1 (en) 2013-03-13 2015-09-24 The Regents Of The University Of Michigan Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof
KR20150135332A (ko) 2013-03-14 2015-12-02 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 미토콘드리아 알데히드 탈수소효소-2 조절인자들 및 이들의 사용 방법
TW201524952A (zh) 2013-03-15 2015-07-01 Araxes Pharma Llc Ｋｒａｓ ｇ１２ｃ之共價抑制劑
US9346802B2 (en) 2013-03-15 2016-05-24 Epizyme, Inc. CARM1 inhibitors and uses thereof
AU2014234472A1 (en) 2013-03-20 2015-10-29 Bayer Pharma Aktiengesellschaft 3-acetylamino-1-(phenyl-heteroaryl-aminocarbonyl or phenyl-heteroaryl-carbonylamino)benzene derivatives for the treatment of hyperproliferative disorders
KR101599009B1 (ko) 2013-03-29 2016-03-14 동아에스티 주식회사 Cetp 억제 활성을 갖는 신규한 옥사졸리디논 유도체, 이의 제조방법 및 이를 포함하는 약학 조성물
AR096022A1 (es) 2013-04-11 2015-12-02 Basf Se Compuestos de pirimidinio sustituido, útiles para combatir plagas de animales
CN103193702B (zh) 2013-04-18 2014-12-24 陕西师范大学 含氮杂环化合物官能团化的方法
ITMI20130647A1 (it) 2013-04-19 2014-10-20 Univ Bologna Alma Mater Composti con attività inibente sulle sirtuine
WO2014186450A2 (fr) 2013-05-14 2014-11-20 The Board Of Regents Of The University Of Texas System Inhibiteurs très puissants de porc-épic
MX2015015844A (es) 2013-05-17 2016-03-04 Basf Se Proceso para preparar compuestos n-sustituidos de acido 1h-pirazol-5-carboxilico y sus derivados.
JP6468186B2 (ja) 2013-05-31 2019-02-13 コニカミノルタ株式会社 透明電極、電子デバイス及び有機エレクトロルミネッセンス素子
WO2014200882A1 (fr) 2013-06-11 2014-12-18 Janssen Pharmaceutica Nv Inhibiteurs de pde10a pour le traitement du diabète de type ii
JP6184830B2 (ja) 2013-06-14 2017-08-23 花王株式会社 漂白洗浄剤組成物
PT3013796T (pt) 2013-06-27 2020-03-26 Lg Chemical Ltd Derivados biarílicos como agonistas de gpr120
WO2015004029A1 (fr) 2013-07-08 2015-01-15 Technische Universität München Marquage au 18f de molécules aromatiques et hétéroaromatiques contenant des groupements d'acide carboxylique non protégés
EP3027590A1 (fr) 2013-07-31 2016-06-08 Minoryx Therapeutics S.L. Di(hétéro)arylamides et sulfonamides, procédés permettant leur préparation et utilisations thérapeutiques de ceux-ci
JPWO2015015993A1 (ja) 2013-08-01 2017-03-02 コニカミノルタ株式会社 有機エレクトロルミネッセンス素子
US20160193202A1 (en) 2013-08-12 2016-07-07 Adispell, Inc. Therapeutic treatment for drug poisoning and addiction
WO2015025172A1 (fr) 2013-08-22 2015-02-26 Mark David Charles Composés 5-aryl-thiazol -2-yl-amine et leur utilisation thérapeutique
WO2015025962A1 (fr) 2013-08-23 2015-02-26 富山化学工業株式会社 Composé amidine ou sel associé
US9359330B2 (en) 2013-08-26 2016-06-07 Purdue Pharma L.P. Substituted piperidines as sodium channel blockers
WO2015031561A1 (fr) 2013-08-30 2015-03-05 Bp Corporation North America Inc. Conversion catalytique d'alcools
JP2016540725A (ja) 2013-10-04 2016-12-28 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ 炭化水素の酸化を触媒することのできる分子触媒および炭化水素を酸化する方法
DE102013016324A1 (de) 2013-10-04 2015-04-09 Merck Patent Gmbh Perfluoralkylfluor- oder Perfluoralkylchlorgermanate
DK3063143T3 (en) 2013-11-01 2018-08-20 Novartis Ag Amino heteroaryl benzamides as kinase inhibitors
WO2015066697A1 (fr) 2013-11-04 2015-05-07 Forum Pharmaceuticals Inc. Morpholinopyrimidines fusionnées et procédés d'utilisation de ces dernières
US10033000B2 (en) 2013-11-15 2018-07-24 Universal Display Corporation Organic electroluminescent materials and devices
US9340504B2 (en) 2013-11-21 2016-05-17 Purdue Pharma L.P. Pyridine and piperidine derivatives as novel sodium channel blockers
US9708278B2 (en) 2013-11-27 2017-07-18 Vanderbilt University Substituted 4-benzyl-3,4-dihydro-2H-benzo[B][1,4]oxazine-2-carboxamide analogs as positive allosteric modulators of muscarinic acetycholine receptor M1
CN105960237B (zh) 2013-12-02 2020-03-31 凯莫森特里克斯股份有限公司 Ccr6化合物
US10355227B2 (en) 2013-12-16 2019-07-16 Universal Display Corporation Metal complex for phosphorescent OLED
GB201322334D0 (en) 2013-12-17 2014-01-29 Agency Science Tech & Res Maleimide derivatives as modulators of WNT pathway
WO2015089809A1 (fr) 2013-12-19 2015-06-25 Merck Sharp & Dohme Corp. Composés hétéroaryles substitués antidiabétiques
US9682960B2 (en) 2013-12-19 2017-06-20 Endorecherche, Inc. Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety
AU2014369053B2 (en) 2013-12-20 2019-03-14 Institute For Drug Discovery, Llc Substituted amino triazoles, and methods using same
KR20160098506A (ko) 2013-12-20 2016-08-18 라보라토리오스 델 드라. 에스테브.에스.에이. 통증에 대한 다양한 활성을 갖는 피페라진 유도체
JP6340788B2 (ja) 2013-12-25 2018-06-13 コニカミノルタ株式会社 透明電極及び電子デバイス
JP2015125845A (ja) 2013-12-26 2015-07-06 コニカミノルタ株式会社 透明電極及び電子デバイス
US10266515B2 (en) 2013-12-30 2019-04-23 Lifesci Pharmaceuticals, Inc. Therapeutic inhibitory compounds
WO2015109109A1 (fr) 2014-01-15 2015-07-23 Forum Pharmaceuticals Inc. Morpholino-pyrimidines fusionnées et leurs procédés d'utilisation
ES2699351T3 (es) 2014-01-17 2019-02-08 Novartis Ag Derivados de 1-piridazin/triazin-3-il-piper(-azina)/idina/pirolidina y composiciones de las mismas para inhibir la actividad de SHP2
CN103848838A (zh) 2014-01-23 2014-06-11 中国药科大学 一类c-Met与VEGFR-2双重拮抗剂、其制备方法及其医疗用途
JP2015141806A (ja) 2014-01-28 2015-08-03 出光興産株式会社 有機エレクトロルミネッセンス素子の製造方法、組成物、有機エレクトロルミネッセンス素子、および電子機器
CN103804312B (zh) 2014-02-17 2016-04-20 四川百利药业有限责任公司 一类氮杂环化合物及其制备方法和用途
US9673407B2 (en) 2014-02-28 2017-06-06 Universal Display Corporation Organic electroluminescent materials and devices
WO2015138273A1 (fr) 2014-03-13 2015-09-17 Merck Sharp & Dohme Corp. Composés 2-pyrazine carboxamide utiles comme inhibiteurs de la tyrosine kinase splénique
MX2016011992A (es) 2014-03-17 2016-12-05 Hoffmann La Roche Derivados de piperidina-diona.
WO2015142903A2 (fr) 2014-03-17 2015-09-24 Genentech, Inc. Procédé pour réguler la production de lactate à l'aide de dérivés de pipéridine-dione
WO2015139621A1 (fr) 2014-03-18 2015-09-24 北京韩美药品有限公司 Acide benzoïque 4-hétéroaryle substitué ou composé de benzamides
CN106573880B (zh) 2014-03-19 2019-07-30 阿米达斯公司 淀粉样蛋白靶向剂及其使用方法
CN104926801B (zh) 2014-03-22 2019-06-04 浙江大学 取代氮杂环类衍生物、含其的药物组合物及其在抗肿瘤中的应用
JP6269260B2 (ja) 2014-03-31 2018-01-31 宇部興産株式会社 ビアリール化合物の製造方法
EP2933849A1 (fr) 2014-04-15 2015-10-21 cynora GmbH Matériaux hôtes pour des diodes électroluminescentes organiques
WO2015160636A1 (fr) 2014-04-16 2015-10-22 Merck Sharp & Dohme Corp. Inhibiteurs du facteur ixa
CA2945212A1 (fr) * 2014-04-24 2015-10-29 Novartis Ag Derives amines de pyrazine utilisables en tant qu'inhibiteurs de la phosphatidylinositol 3-kinase
AU2014391610B2 (en) * 2014-04-24 2018-01-25 Novartis Ag Pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
JP6599361B2 (ja) 2014-04-29 2019-10-30 マイクロベンション インコーポレイテッド 活性剤を含むポリマー
US9981972B2 (en) 2014-05-22 2018-05-29 Abide Therapeutics, Inc. N-hydroxy bicyclic hydantoin carbamates as tools for identification of serine hydrolase targets
CN105461738B (zh) 2014-06-03 2019-03-08 中国人民解放军军事医学科学院毒物药物研究所 一种雷帕霉素衍生物、其制备方法、其药物组合物及用途
CN104004026A (zh) 2014-06-09 2014-08-27 江西冠能光电材料有限公司 一种电负性磷光材料
US11179394B2 (en) 2014-06-17 2021-11-23 Vertex Pharmaceuticals Incorporated Method for treating cancer using a combination of Chk1 and ATR inhibitors
CN106573931A (zh) 2014-06-18 2017-04-19 拜耳医药股份有限公司 抑制BET蛋白的具有间位取代的芳族氨基或醚基的3，4‑二氢吡啶并[2，3‑b]吡嗪酮
GB201411239D0 (en) 2014-06-25 2014-08-06 Takeda Pharmaceutical Novel compounds
GB201411236D0 (en) 2014-06-25 2014-08-06 Takeda Pharmaceutical Novel compounds
JP6204591B2 (ja) 2014-07-07 2017-09-27 富士フイルム株式会社 光電変換素子、色素増感太陽電池、金属錯体色素、色素溶液、およびターピリジン化合物またはそのエステル化物
CN106463273B (zh) 2014-07-07 2019-01-15 富士胶片株式会社 光电转换元件、色素增感太阳能电池、金属络合物色素、色素溶液、以及三联吡啶化合物或其酯化物
CN105315199B (zh) 2014-07-14 2020-11-20 湖南化工研究院有限公司 N-吡啶芳氧苯氧羧酸衍生物及其制备方法与应用
JP6362235B2 (ja) 2014-07-14 2018-07-25 ツーセン ファーマシューティカル カンパニー リミテッド ピリジン誘導体およびその抗マイコバクテリウムにおける使用
EP3172205A1 (fr) 2014-07-23 2017-05-31 Aurigene Discovery Technologies Limited Dérivés de 4,5-dihydroisoxazole comme inhibiteurs de nampt
CA2955919A1 (fr) 2014-07-25 2016-01-28 Piramal Enterprises Limited Composes d'acide phenylalcanoique substitue utilisables en tant qu'agonistes de gpr120 et leurs utilisations
MA40404A (fr) 2014-08-05 2017-06-14 Alios Biopharma Inc Polythérapie pour traiter un paramyxovirus
JO3589B1 (ar) 2014-08-06 2020-07-05 Novartis Ag مثبطات كيناز البروتين c وطرق استخداماتها
KR101887213B1 (ko) 2014-08-12 2018-08-09 삼성에스디아이 주식회사 화합물, 이를 포함하는 유기 광전자 소자 및 표시장치
CN105829318B (zh) 2014-08-18 2018-10-02 哈德森生物医药有限公司 作为mdm2抑制剂的螺吡咯烷
US20170290806A1 (en) 2014-09-08 2017-10-12 Temple University-Of The Commonwealth System Of Higher Education PCSK9 Inhibitors and Methods of Use Thereof
US10669635B2 (en) 2014-09-18 2020-06-02 Baker Hughes, A Ge Company, Llc Methods of coating substrates with composite coatings of diamond nanoparticles and metal
US9862701B2 (en) 2014-09-25 2018-01-09 Araxes Pharma Llc Inhibitors of KRAS G12C mutant proteins
WO2016049565A1 (fr) 2014-09-25 2016-03-31 Araxes Pharma Llc Compositions et procédés pour inhiber la ras
JP6100745B2 (ja) 2014-10-01 2017-03-22 ユー・ディー・シー アイルランド リミテッド 有機電界発光素子
EP3201187A4 (fr) 2014-10-01 2018-04-11 The Brigham and Women's Hospital, Inc. Compositions et procédés d'inhibition de bmp
SMT201900615T1 (it) 2014-10-08 2020-01-14 Redx Pharma Plc Derivati di acetammide n-piridinile come inibitori del percorso di segnalazione wnt
BR112017007218B1 (pt) 2014-10-08 2023-10-10 Redx Pharma Plc Derivados de n-piridil acetamida como inibidores da via de sinalização de wnt, formulações farmacêuticas compreendendo os mesmos e seus usos
US10174012B2 (en) 2014-11-04 2019-01-08 The University Of Kansas LKB1-AMPK activators for therapeutic use in polycystic kidney disease
WO2016073623A2 (fr) 2014-11-04 2016-05-12 Northwestern University Inhibiteurs d'oxyde nitrique synthase d'origine bactérienne et mammalienne
US10759791B2 (en) 2014-11-04 2020-09-01 Northwestern University Mammalian and bacterial nitric oxide synthase inhibitors
WO2016074757A1 (fr) 2014-11-11 2016-05-19 Merck Patent Gmbh Procédé de production des sels de mono(perfluoroalkyl)fluorophosphate et de bis(perfluoroalkyl)fluorophosphate et leurs acides
WO2016088354A1 (fr) 2014-12-05 2016-06-09 出光興産株式会社 Composé de complexe métallique, matériau pour élément électroluminescent organique, composition, élément électroluminescent organique, et dispositif électronique
CN104557863B (zh) 2014-12-18 2017-03-15 中国科学院广州生物医药与健康研究院 一种新型烟酰胺磷酸核糖转移酶抑制剂及其合成方法与应用
WO2016097918A1 (fr) 2014-12-18 2016-06-23 Pfizer Inc. Dérivés de pyrimidine et de triazine, et leur utilisation comme inhibiteurs d'axl
MY191736A (en) 2014-12-23 2022-07-13 Axikin Pharmaceuticals Inc 3,5-diaminopyrazole kinase inhibitors
JP6502091B2 (ja) 2014-12-26 2019-04-17 国立研究開発法人産業技術総合研究所 高圧水素製造法および製造システム
US10544361B2 (en) 2015-01-20 2020-01-28 Cynora Gmbh Pyridines and derivatives thereof as components for use in optoelectronic components
CN105845831B (zh) 2015-01-30 2019-07-05 三星显示有限公司 有机发光装置
US20180022990A1 (en) 2015-02-03 2018-01-25 Sumitomo Chemical Company, Limited Composition and light emitting device using the same
WO2016130501A1 (fr) 2015-02-09 2016-08-18 Incyte Corporation Composés aza-hétéroaryle en tant qu'inhibiteurs de pi3k-gamma
CN104744348B (zh) 2015-02-13 2018-01-09 华侨大学 多取代吡啶衍生物及其制备方法
US9701671B2 (en) 2015-02-20 2017-07-11 Canon Kabushiki Kaisha Organic compound, electrochromic element containing the same, optical filter, lens unit, imaging device, and window component
SG10201912302VA (en) 2015-02-27 2020-02-27 Incyte Corp Salts of pi3k inhibitor and processes for their preparation
US10577349B2 (en) 2015-03-02 2020-03-03 Sanford Burnham Prebys Medical Discovery Institute Quinolinones as inhibitors of translation initiation complex
US10766860B2 (en) 2015-03-06 2020-09-08 Pharmakea, Inc. Lysyl oxidase-like 2 inhibitors and uses thereof
US10710978B2 (en) 2015-03-31 2020-07-14 Dana-Farber Cancer Institute, Inc. STK4 inhibitors for treatment of hematologic malignancies
US11021468B2 (en) 2015-04-01 2021-06-01 Rigel Pharmaceuticals, Inc. TGF-ß inhibitors
AR104274A1 (es) 2015-04-08 2017-07-12 Torrent Pharmaceuticals Ltd Compuestos piridinio como inhibidores de pag
KR101953175B1 (ko) 2015-04-24 2019-02-28 주식회사 엘지화학 함질소 다환 화합물 및 이를 이용하는 유기 발광 소자
WO2016173557A1 (fr) 2015-04-30 2016-11-03 中国科学院上海药物研究所 Composé ayant une activité d'inhibition de kinase, procédé de préparation et utilisations
CA2984183C (fr) 2015-05-01 2021-11-09 Pfizer Inc. Pyrrolo [2,3-d] pyrimidinyl, pyrrolo[2,3-b] pyrazinyl, pyrrolo [2,3-b] pyridinyl acrylamides et leur epoxydes
GB201507753D0 (en) 2015-05-06 2015-06-17 Biolipox Ab New compounds and uses
JP7083247B2 (ja) 2015-05-08 2022-06-10 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 発光材料、発光性薄膜、有機エレクトロルミネッセンス素子、表示装置及び照明装置
US20160340311A1 (en) 2015-05-22 2016-11-24 Dow Agrosciences Llc Recovery and/or reuse of palladium catalyst after a suzuki coupling
US11925102B2 (en) 2015-06-04 2024-03-05 Universal Display Corporation Organic electroluminescent materials and devices
CN104927742B (zh) 2015-06-23 2017-05-17 上海东和胶粘剂有限公司 聚氨酯木结构胶及其制备方法
JP2017019789A (ja) 2015-07-13 2017-01-26 大阪ガスケミカル株式会社 微生物防除剤
WO2017011279A1 (fr) 2015-07-13 2017-01-19 Merck Sharp & Dohme Corp. Hétérocycles bicycliques en tant qu'inhibiteurs de la protéine de transfert des esters de cholestérol
CN105175202B (zh) 2015-07-14 2018-09-07 绍兴文理学院 由芳香肼制备联芳烃的方法
TWI608132B (zh) 2015-08-06 2017-12-11 羅門哈斯電子材料有限公司 自含有吡啶基烷基胺及雙環氧化物之反應產物的銅電鍍覆浴液電鍍覆光阻劑限定之特徵的方法
KR101735687B1 (ko) 2015-09-23 2017-05-15 롯데케미칼 주식회사 올레핀 올리고머화용 촉매계 및 이를 이용한 올레핀 올리고머화 방법
KR101832448B1 (ko) 2015-09-24 2018-02-26 롯데케미칼 주식회사 올레핀 올리고머화용 촉매계, 및 이를 이용한 올레핀 올리고머화 방법
US20170092880A1 (en) 2015-09-25 2017-03-30 Universal Display Corporation Organic electroluminescent materials and devices
EP3356347A1 (fr) 2015-09-28 2018-08-08 Araxes Pharma LLC Inhibiteurs de protéines kras portant la mutation g12c
WO2017058728A1 (fr) 2015-09-28 2017-04-06 Araxes Pharma Llc Inhibiteurs de protéines kras portant la mutation g12c
US11464774B2 (en) 2015-09-30 2022-10-11 Vertex Pharmaceuticals Incorporated Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
WO2017059434A1 (fr) 2015-10-02 2017-04-06 Esanex, Inc. Utilisation de dérivés tétrahydroindolylbenzamide et de tétrahydroindazolylbenzamide pour le traitement du cancer
US10174002B2 (en) 2015-10-07 2019-01-08 NuBridge BioSciences Pyridine derivatives as CFTR modulators
US9890149B2 (en) 2015-10-07 2018-02-13 NuBridge BioSciences Isothiazole derivatives as CFTR modulators
US9981945B2 (en) 2015-10-07 2018-05-29 NuBridge BioSciences Pyrimidine derivatives as CFTR modulators
WO2017061581A1 (fr) 2015-10-08 2017-04-13 株式会社神鋼環境ソリューション Procédé de synthèse d'un composé de bipyridine et procédé de fabrication d'un composé de pyridine
BR112018007068B1 (pt) 2015-10-09 2024-01-02 Janssen Pharmaceutica N.V. Derivados de quinoxalina e piridopirazina como inibidores de pi3kbeta, seu uso e composição farmacêutica que os compreende
WO2017070003A1 (fr) 2015-10-20 2017-04-27 Kiacta Sárl Utilisation de promédicaments composés d'acide 1,3-propane disulfonique ou de sels pharmaceutiquement acceptable de celui-ci pour le traitement de la sarcoïdose
JP6917989B2 (ja) 2015-11-06 2021-08-11 ニューロクライン バイオサイエンシーズ，インコーポレイテッド 神経学的疾患を処置するためのムスカリン受容体４（ｍ４）アンタゴニストとしての、ｎ−［２−（１−ベンジルピペリジン−４−イル）エチル］−４−（ピラジン−２−イル）−ピペラジン−１−カルボキサミド誘導体および関連化合物
JP7085994B2 (ja) 2015-11-17 2022-06-17 博蔚醫藥生物科技股▲ふん▼有限公司 線維症疾患の治療及び／又は予防用アミノナフトキノン化合物
CN107056755B (zh) 2015-12-07 2019-02-22 苏州信诺维医药科技有限公司 五元杂环酰胺类wnt通路抑制剂
US20180360782A1 (en) 2015-12-09 2018-12-20 Case Western Reserve University Method of modulating ribonucleotide reductase
TWI773657B (zh) 2015-12-18 2022-08-11 美商亞德利克斯公司 作爲非全身ｔｇｒ５促效劑之經取代之4-苯基吡啶化合物
KR102419178B1 (ko) 2015-12-29 2022-07-11 삼성디스플레이 주식회사 유기 발광 소자
KR102396293B1 (ko) 2015-12-29 2022-05-11 삼성디스플레이 주식회사 유기 발광 소자
ES2995198T3 (en) 2016-01-05 2025-02-07 Incyte Corp Pyridine compounds as pi3k-gamma inhibitors
US12233060B2 (en) 2016-01-08 2025-02-25 The Institute Of Cancer Research: Royal Cancer Hospital Inhibitors of Ataxia-Telangiectasia Mutated and Rad3-related protein kinase (ATR) for use in methods of treating cancer
WO2017127637A1 (fr) 2016-01-22 2017-07-27 Chevron Oronite Company Llc Composition d'huile lubrifiante synergique contenant en mélange un agent améliorant la viscosité de type dispersant à base de copolymère d'oléfine et un composé d'amine
JP6380692B2 (ja) 2016-01-28 2018-08-29 住友化学株式会社 膜の製造方法
KR20170093273A (ko) 2016-02-03 2017-08-16 주식회사 동진쎄미켐 유기발광소자
WO2017170765A1 (fr) 2016-03-30 2017-10-05 田辺三菱製薬株式会社 Nouveau composé hétérocyclique contenant de l'azote
US10236456B2 (en) 2016-04-11 2019-03-19 Universal Display Corporation Organic electroluminescent materials and devices
US10865205B2 (en) 2016-04-22 2020-12-15 Dana-Farber Cancer Institute, Inc. Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use
US20170305861A1 (en) 2016-04-25 2017-10-26 Immunomet Therapeutics, Inc Heteroaryl compounds comprising nitrogen and use thereof
WO2017189569A1 (fr) 2016-04-25 2017-11-02 Trustees Of Tufts College Inhibiteurs de dpp4 et de fap multimédiateurs, et utilisations associées
ES2906460T3 (es) 2016-05-06 2022-04-18 Incyte Corp Compuestos heterocíclicos como inmunomoduladores
WO2017197046A1 (fr) 2016-05-10 2017-11-16 C4 Therapeutics, Inc. Dégronimères de type glutarimide liés au carbone c3 pour la dégradation de protéines cibles
TW201803871A (zh) 2016-06-24 2018-02-01 英塞特公司 作為ＰＩ３Ｋ-γ抑制劑之雜環化合物
AU2017294231B2 (en) 2016-07-05 2021-09-09 Guangzhou Maxinovel Pharmaceuticals Co., Ltd Aromatic acetylene or aromatic ethylene compound, intermediate, preparation method, pharmaceutical composition and use thereof
CN107759614B (zh) 2016-08-16 2023-01-24 中国科学院上海药物研究所 一类噁唑并吡啶季铵盐类化合物、其制备方法及用途
CN109863142B (zh) 2016-08-24 2022-06-10 豪夫迈·罗氏有限公司 2-氮杂双环[3.1.0]己烷-3-酮衍生物及使用方法
PL3507289T3 (pl) 2016-09-02 2021-01-25 Suven Life Sciences Limited Dodatnie allosteryczne modulatory receptora muskarynowego m1
CN109790081A (zh) 2016-09-21 2019-05-21 乐天化学株式会社 烯烃低聚的催化剂体系和使用其制备烯烃低聚物的方法
US10981154B2 (en) 2016-09-21 2021-04-20 Lotte Chemical Corporation Catalyst system for olefin oligomerization and method for preparing olefin oligomer using same
AU2017337946B2 (en) 2016-09-28 2020-05-07 Dong-A St Co., Ltd. Tetrahydropyridine derivatives and their use as antibacterial agents
TWI734861B (zh) 2016-12-19 2021-08-01 瑞典商指紋卡公司 包括顯示功能之電容式指紋感測裝置
CN106831735B (zh) 2017-01-23 2019-10-11 牡丹江医学院 一种治疗骨质疏松的杂环化合物及其制备方法和用途
CN106905299B (zh) 2017-02-28 2019-04-02 牡丹江医学院 一种治疗胰腺炎的药物及其制备方法
KR102717072B1 (ko) * 2017-10-18 2024-10-15 인사이트 코포레이션 Pi3k-감마 저해제로서의 3차 하이드록시기로 치환된 축합된 이미다졸 유도체
CR20200464A (es) 2018-03-08 2021-04-14 Incyte Corp Compuestos diólicos de aminopirazina como inhibidores de pi3k-y
WO2020010003A1 (fr) 2018-07-02 2020-01-09 Incyte Corporation DÉRIVÉS D'AMINOPYRAZINE UTILISÉS EN TANT QU'INHIBITEURS DE PI3K-γ

Also Published As

Publication number Publication date
JP7558334B2 (ja) 2024-09-30
JP7268049B2 (ja) 2023-05-02
KR102828717B1 (ko) 2025-07-07
PE20210641A1 (es) 2021-03-23
CN112074505A (zh) 2020-12-11
TW202413336A (zh) 2024-04-01
PL3762368T3 (pl) 2022-06-06
IL302529A (en) 2023-07-01
AU2019272342A1 (en) 2020-09-24
PE20251292A1 (es) 2025-05-14
SMT202200134T1 (it) 2022-05-12
EP3762368A2 (fr) 2021-01-13
IL277071A (en) 2020-10-29
HRP20220331T1 (hr) 2022-05-13
IL277071B2 (en) 2024-07-01
US20240400541A1 (en) 2024-12-05
CO2020012169A2 (es) 2020-12-21
US20190276435A1 (en) 2019-09-12
US20200339542A1 (en) 2020-10-29
MX2023000100A (es) 2023-02-09
CN118290402A (zh) 2024-07-05
TW201938542A (zh) 2019-10-01
PH12020551390A1 (en) 2021-11-22
JP2021515773A (ja) 2021-06-24
BR112020018094A2 (pt) 2020-12-22
CR20240101A (es) 2024-05-24
US20250313550A1 (en) 2025-10-09
CA3093445A1 (fr) 2019-11-28
AU2024203916B2 (en) 2026-07-30
WO2019226213A3 (fr) 2020-01-02
ECSP20061378A (es) 2021-04-29
EP4056560A1 (fr) 2022-09-14
ES2910071T3 (es) 2022-05-11
SG11202008560VA (en) 2020-10-29
IL302529B2 (en) 2025-03-01
IL302529B1 (en) 2024-11-01
SI3762368T1 (sl) 2022-06-30
TWI903299B (zh) 2025-11-01
KR102960631B1 (ko) 2026-05-06
AU2024203916A1 (en) 2024-06-27
KR20200142508A (ko) 2020-12-22
JP2023099049A (ja) 2023-07-11
AU2019272342B2 (en) 2024-03-07
CL2020002275A1 (es) 2021-02-19
CN112074505B (zh) 2024-04-05
HUE057970T2 (hu) 2022-06-28
MA54133A (fr) 2021-01-13
UA128288C2 (uk) 2024-05-29
US20220213065A1 (en) 2022-07-07
RS63124B1 (sr) 2022-05-31
MD3762368T2 (ro) 2022-07-31
DK3762368T3 (da) 2022-03-28
EP3762368B1 (fr) 2022-01-26
IL277071B1 (en) 2024-03-01
TWI827583B (zh) 2024-01-01
LT3762368T (lt) 2022-06-10
WO2019226213A2 (fr) 2019-11-28
US11926616B2 (en) 2024-03-12
MX2020009228A (es) 2021-01-08
PT3762368T (pt) 2022-05-06
CY1125169T1 (el) 2024-02-16
CR20200464A (es) 2021-04-14
US12365668B2 (en) 2025-07-22
KR20250103804A (ko) 2025-07-07
US10669262B2 (en) 2020-06-02

Similar Documents

Publication Publication Date Title
MA54133A (fr) Composés d'aminopyrazine diol utilisés comme inhibiteurs de pi3k-y
MA43169B1 (fr) Composés héterocycliques en tant qu' inhibiteurs pi3k-gamma
MA50398B1 (fr) Dérivés d'imidazole condensés, substitués par des groupes hydroxy tertiaires, utilisés comme inhibiteurs de pi3k-gamma
MA52486B1 (fr) Pyridazinones utilisés en tant qu'inhibiteurs de parp7
MA64509B1 (fr) Composés hétérocycliques utilisés comme immunomodulateurs
MA64121B1 (fr) Composés hétérocycliques utilisés comme immunomodulateurs
GEAP202315746A (en) Protein tyrosine phosphatase inhibitors
MA62580B1 (fr) Amines bicycliques utilisées en tant qu'inhibiteurs de cdk2
MA39219B1 (fr) Nouveaux composés inhibiteurs de la kinase lrrk2 utilisés pour le traitement du parkinson, de l’alzheimer et de la sclérose latérale amyotrophique
MA51530B1 (fr) Composés cycliques fondus
JOP20230036A1 (ar) نواهض مستقبل أوريكسين بيروليدين سيكلوهيبتان
MA31655B1 (fr) Pyrimidines cyclopenta [d] hydroxylés et méthoxylés utilisés en tant qu'inhibiteurs de la protéine kinase akt.
MA44674B1 (fr) Inhibiteurs de bromodomaine
MA30358B1 (fr) Quinazolines pour l'inhibition de pdk1
MA43756B1 (fr) Modulateurs allostériques des récepteurs nicotiniques de l'acétylcholine
MA37762A1 (fr) Composés n-aryltriazole utilisés comme antagonistes de lpar
MA40955B1 (fr) 2-amino-6-(difluorométhyl)-5,5-difluoro-6-phényl-3,4,5,6-tétrahydropyridines comme inhibiteurs de bace1
MA37764A1 (fr) Composés n-alkyltriazole utilisés comme antagonistes de lpar
MA50013B1 (fr) Analogues de benzoazépine utilisés en tant qu'agents inhibiteurs de la tyrosine kinase de bruton
PH12021550743A1 (en) Boron containing pde4 inhibitors
MA46229B1 (fr) Composés d'hétéroaryle carboxamide en tant qu'inhibiteurs de ripk2
MA37765A1 (fr) Composés de pyrazole substitués utilisés comme antagonistes de lpar
PH12022500015A1 (en) Ccr6 receptor modulators
MX2023009059A (es) Antagonistas de gpr84 y usos de estos.
MA52375A1 (fr) Inhibiteurs de cdk8/19